0001850938FALSE2026Q212/31oneoneP1MP3Moneonexbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purewti:segmentwti:class_of_financial_instrument00018509382026-01-012026-06-3000018509382026-08-1300018509382026-06-3000018509382025-12-310001850938wti:CumulativeReturnOfCapitalDistributionsMember2026-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-12-310001850938wti:DistributableIncomeLossMember2026-06-300001850938wti:DistributableIncomeLossMember2025-12-3100018509382026-04-012026-06-3000018509382025-04-012025-06-3000018509382025-01-012025-06-300001850938us-gaap:CommonStockMember2025-03-310001850938us-gaap:AdditionalPaidInCapitalMember2025-03-310001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-03-310001850938wti:DistributableIncomeLossMember2025-03-3100018509382025-03-310001850938wti:DistributableIncomeLossMember2025-04-012025-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-04-012025-06-300001850938us-gaap:CommonStockMember2025-06-300001850938us-gaap:AdditionalPaidInCapitalMember2025-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-06-300001850938wti:DistributableIncomeLossMember2025-06-3000018509382025-06-300001850938us-gaap:CommonStockMember2026-03-310001850938us-gaap:AdditionalPaidInCapitalMember2026-03-310001850938wti:CumulativeReturnOfCapitalDistributionsMember2026-03-310001850938wti:DistributableIncomeLossMember2026-03-3100018509382026-03-310001850938wti:DistributableIncomeLossMember2026-04-012026-06-300001850938us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-300001850938us-gaap:CommonStockMember2026-06-300001850938us-gaap:AdditionalPaidInCapitalMember2026-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2026-06-300001850938wti:DistributableIncomeLossMember2026-06-300001850938us-gaap:CommonStockMember2024-12-310001850938us-gaap:AdditionalPaidInCapitalMember2024-12-310001850938wti:CumulativeReturnOfCapitalDistributionsMember2024-12-310001850938wti:DistributableIncomeLossMember2024-12-3100018509382024-12-310001850938wti:DistributableIncomeLossMember2025-01-012025-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-01-012025-06-300001850938us-gaap:AdditionalPaidInCapitalMember2025-01-012025-06-300001850938us-gaap:CommonStockMember2025-12-310001850938us-gaap:AdditionalPaidInCapitalMember2025-12-310001850938wti:CumulativeReturnOfCapitalDistributionsMember2025-12-310001850938wti:DistributableIncomeLossMember2025-12-310001850938wti:DistributableIncomeLossMember2026-01-012026-06-300001850938wti:CumulativeReturnOfCapitalDistributionsMember2026-01-012026-06-300001850938us-gaap:AdditionalPaidInCapitalMember2026-01-012026-06-300001850938Biolojic Design Ltd. | Senior Secured2026-06-300001850938Mazen Animal Health Inc. | Senior Secured2026-06-300001850938Teiko Bio, Inc. | Senior Secured 12026-06-300001850938Teiko Bio, Inc. | Senior Secured 22026-06-300001850938wti:TeikoBioInc.Memberwti:LoanInvestmentsBiotechnologyMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMember2026-06-300001850938Proto, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsComputersAndStorageMember2026-06-300001850938BossBites Inc. | Senior Secured2026-06-300001850938D2C Store, Inc. | Senior Secured2026-06-300001850938Findigs, Inc. | Senior Secured2026-06-300001850938OneLocal, Inc. | Senior Secured2026-06-300001850938Quantcast Corp. | Senior Secured2026-06-300001850938Realm Living, Inc. | Senior Secured2026-06-300001850938RetailerX, Inc. | Senior Secured2026-06-300001850938Slice Solutions, Inc. | Senior Secured2026-06-300001850938Threedium, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsInternetMember2026-06-300001850938Akadeum Life Sciences, Inc. | Senior Secured2026-06-300001850938eXo Imaging, Inc. | Senior Secured2026-06-300001850938Gallant Pet, Inc. | Senior Secured 12026-06-300001850938Gallant Pet, Inc. | Senior Secured 22026-06-300001850938Gallant Pet, Inc. | Senior Secured 32026-06-300001850938wti:GallantPetInc.Memberwti:LoanInvestmentsMedicalDevicesMember2026-06-300001850938wti:LoanInvestmentsMedicalDevicesMember2026-06-300001850938Charlie Financial Inc. | Senior Secured2026-06-300001850938GoForward, Inc. | Senior Secured2026-06-300001850938Lark Technologies, Inc. | Senior Secured2026-06-300001850938MeMed Diagnostics Ltd. | Senior Secured 12026-06-300001850938MeMed Diagnostics Ltd. | Senior Secured 22026-06-300001850938MeMed Diagnostics Ltd. | Senior Secured 32026-06-300001850938wti:MeMedDiagnosticsLtdMemberwti:LoanInvestmentsOtherHealthcareMember2026-06-300001850938Vitable, Inc. | Senior Secured 12026-06-300001850938Vitable, Inc. | Senior Secured 22026-06-300001850938wti:VitableInc.Memberwti:LoanInvestmentsOtherHealthcareMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMember2026-06-300001850938AI Tech Holdings, Inc. | Senior Secured2026-06-300001850938Allocate Holdings Inc. | Senior Secured2026-06-300001850938American Castanea PBC | Senior Secured 12026-06-300001850938American Castanea PBC | Senior Secured 22026-06-300001850938wti:AmericanCastaneaPBCMemberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Azumo, Inc. | Senior Secured2026-06-300001850938Badiani Limited | Senior Secured2026-06-300001850938Belong, Inc. | Senior Secured 12026-06-300001850938Belong, Inc. | Senior Secured 22026-06-300001850938Belong, Inc. | Senior Secured 32026-06-300001850938wti:BelongInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Brick Dynamics Inc. | Senior Secured 12026-06-300001850938Brick Dynamics Inc. | Senior Secured 22026-06-300001850938wti:BrickDynamicsInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Bryte, Inc. | Senior Secured2026-06-300001850938Carbon Ridge, Inc. | Senior Secured 12026-06-300001850938Carbon Ridge, Inc. | Senior Secured 22026-06-300001850938wti:CarbonRidgeInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Cella Farms Inc. | Senior Secured2026-06-300001850938Cofertility, Inc. | Senior Secured2026-06-300001850938Coffee.ai Inc. | Senior Secured2026-06-300001850938CornerUp, Inc. | Senior Secured2026-06-300001850938Creoate Limited | Senior Secured 12026-06-300001850938Creoate Limited | Senior Secured 22026-06-300001850938Creoate Limited | Senior Secured 32026-06-300001850938Creoate Limited | Senior Secured 42026-06-300001850938Creoate Limited | Senior Secured 52026-06-300001850938Creoate Limited | Senior Secured 62026-06-300001850938Creoate Limited | Senior Secured 72026-06-300001850938Creoate Limited | Senior Secured 82026-06-300001850938Creoate Limited | Senior Secured 92026-06-300001850938Creoate Limited | Senior Secured 102026-06-300001850938Creoate Limited | Senior Secured 112026-06-300001850938Creoate Limited | Senior Secured 122026-06-300001850938Creoate Limited | Senior Secured 132026-06-300001850938Creoate Limited | Senior Secured 142026-06-300001850938Creoate Limited | Senior Secured 152026-06-300001850938Creoate Limited | Senior Secured 162026-06-300001850938Creoate Limited | Senior Secured 172026-06-300001850938Creoate Limited | Senior Secured 182026-06-300001850938wti:CreoateLimitedMemberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Daisyco, Inc. | Senior Secured2026-06-300001850938Eguana Technologies, Inc. | Senior Secured2026-06-300001850938Fanimal, Inc. | Senior Secured2026-06-300001850938Fortull, Inc. | Senior Secured 12026-06-300001850938Fortull, Inc. | Senior Secured 22026-06-300001850938wti:FortullInc.Memberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Gold Words, LLC | Senior Secured2026-06-300001850938Grin Technology Services Inc. | Senior Secured2026-06-300001850938Heading Health Inc. | Senior Secured2026-06-300001850938High Definition Vehicle Insurance, Inc. | Senior Secured2026-06-300001850938Higher Ground Education, Inc. | Senior Secured2026-06-300001850938Hint, Inc. | Senior Secured2026-06-300001850938Holo, Inc. | Senior Secured2026-06-300001850938Innventure LLC | Senior Secured2026-06-300001850938Joy Memories, Inc | Senior Secured 12026-06-300001850938Joy Memories, Inc | Senior Secured 22026-06-300001850938wti:JoyMemoriesIncMemberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938Kindred Motorworks, Inc. | Senior Secured2026-06-300001850938LendTable Inc. | Senior Secured2026-06-300001850938Logistech Solutions Pte. Ltd. | Senior Secured2026-06-300001850938Mavenform, Inc. | Senior Secured2026-06-300001850938NewGlobe Education, Inc. | Senior Secured2026-06-300001850938Overdrive Products Inc. | Senior Secured2026-06-300001850938Plant Prefab, Inc. | Senior Secured2026-06-300001850938Ripple Foods, PBC | Senior Secured2026-06-300001850938Rise Gardens, Inc. | Senior Secured2026-06-300001850938Romaine Empire, Inc. | Senior Secured2026-06-300001850938Runzy, Inc. | Senior Secured2026-06-300001850938Scripta Insights, Inc. | Senior Secured2026-06-300001850938Supplant, Inc. | Senior Secured2026-06-300001850938TheSquareFoot, Inc. | Senior Secured2026-06-300001850938TomoCredit, Inc. | Senior Secured2026-06-300001850938Umbra Lab, Inc. | Senior Secured 12026-06-300001850938Umbra Lab, Inc. | Senior Secured 22026-06-300001850938Umbra Lab, Inc. | Senior Secured 32026-06-300001850938wti:UmbraLabIncMemberwti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938World Wrapps II, Inc. | Senior Secured2026-06-300001850938Zeno Technologies, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMember2026-06-300001850938D2S, Inc. | Senior Secured2026-06-300001850938Terradepth, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMember2026-06-300001850938Abacum Inc. | Senior Secured 12026-06-300001850938Abacum Inc. | Senior Secured 22026-06-300001850938wti:AbacumInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938APIsecAI, Inc. | Senior Secured 12026-06-300001850938APIsecAI, Inc. | Senior Secured 22026-06-300001850938wti:APIsecAIInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Bito Inc. | Senior Secured2026-06-300001850938Bloomboard, Inc. | Senior Secured2026-06-300001850938BlueCart, Inc. | Senior Secured2026-06-300001850938Bound Rates, Inc. | Senior Secured2026-06-300001850938Canvas Medical, Inc. | Senior Secured2026-06-300001850938Checksum AI, Inc. | Senior Secured2026-06-300001850938Common Sun, Inc | Senior Secured 12026-06-300001850938Common Sun, Inc | Senior Secured 22026-06-300001850938wti:CommonSunIncMemberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Crowded Technologies, Inc. | Senior Secured 12026-06-300001850938Crowded Technologies, Inc. | Senior Secured 22026-06-300001850938wti:CrowdedTechnologiesInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Eskalera, Inc. | Senior Secured2026-06-300001850938Evolver Transformation, Inc. | Senior Secured2026-06-300001850938Family First, Inc | Senior Secured2026-06-300001850938Form Remodel, Inc. | Senior Secured2026-06-300001850938Global Publishing Interactive, Inc. | Senior Secured2026-06-300001850938Ioogo Inc. | Senior Secured2026-06-300001850938Jericho Security, Inc. | Senior Secured2026-06-300001850938Ketch Kloud, Inc. | Senior Secured2026-06-300001850938Kolors, Inc. | Senior Secured 12026-06-300001850938Kolors, Inc. | Senior Secured 22026-06-300001850938wti:KolorsInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Merlyn Mind, Inc. | Senior Secured 12026-06-300001850938Merlyn Mind, Inc. | Senior Secured 22026-06-300001850938Merlyn Mind, Inc. | Senior Secured 32026-06-300001850938wti:MerlynMindInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Migo Money, Inc. | Senior Secured2026-06-300001850938Outbuild Technologies, Inc. | Senior Secured2026-06-300001850938Parkoursc, Inc. | Senior Secured2026-06-300001850938Safe Securities Inc. | Senior Secured 12026-06-300001850938Safe Securities Inc. | Senior Secured 22026-06-300001850938Safe Securities Inc. | Senior Secured 32026-06-300001850938Safe Securities Inc. | Senior Secured 42026-06-300001850938wti:SafeSecuritiesIncMemberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Traction Apps, Inc. | Senior Secured2026-06-300001850938Truepic Inc. | Senior Secured 12026-06-300001850938Truepic Inc. | Senior Secured 22026-06-300001850938wti:TruepicInc.Memberwti:LoanInvestmentsSoftwareMember2026-06-300001850938Vesta Housing, Inc. | Senior Secured 12026-06-300001850938Workspot, Inc. | Senior Secured2026-06-300001850938ZeroCater, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsSoftwareMember2026-06-300001850938Ava Finance, Inc. | Senior Secured 12026-06-300001850938Ava Finance, Inc. | Senior Secured 22026-06-300001850938Ava Finance, Inc. | Senior Secured 32026-06-300001850938Ava Finance, Inc. | Senior Secured 42026-06-300001850938Ava Finance, Inc. | Senior Secured 52026-06-300001850938Ava Finance, Inc. | Senior Secured 62026-06-300001850938Ava Finance, Inc. | Senior Secured 72026-06-300001850938wti:AvaFinanceIncMemberwti:LoanInvestmentsTechnologyServicesMember2026-06-300001850938Klar Holdings Limited | Senior Secured 12026-06-300001850938Klar Holdings Limited | Senior Secured 22026-06-300001850938Klar Holdings Limited | Senior Secured 32026-06-300001850938wti:KlarHoldingsLimitedMemberwti:LoanInvestmentsTechnologyServicesMember2026-06-300001850938Loansnap Holdings Inc. | Senior Secured2026-06-300001850938MAYD Group GmbH | Senior Secured2026-06-300001850938Prima Holdings Limited | Senior Secured2026-06-300001850938Surround Group, Inc. | Senior Secured2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMember2026-06-300001850938Juvo Mobile, Inc. | Senior Secured2026-06-300001850938Nextivity, Inc. | Senior Secured 12026-06-300001850938Nextivity, Inc. | Senior Secured 22026-06-300001850938Nextivity, Inc. | Senior Secured 32026-06-300001850938wti:NextivityInc.Memberwti:LoanInvestmentsWirelessMember2026-06-300001850938wti:LoanInvestmentsWirelessMember2026-06-300001850938srt:MaximumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2026-06-300001850938srt:MinimumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2026-06-300001850938wti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2026-06-300001850938srt:MaximumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate4.00FloorRate2.90Maturity12312027Member2026-06-300001850938srt:MinimumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate4.00FloorRate2.90Maturity12312027Member2026-06-300001850938wti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate4.00FloorRate2.90Maturity12312027Member2026-06-300001850938wti:InterestRateCollarMember2026-06-300001850938Biolojic Design Ltd. | Senior Secured 12025-12-310001850938Biolojic Design Ltd. | Senior Secured 22025-12-310001850938Biolojic Design Ltd. | Senior Secured 32025-12-310001850938wti:BiolojicDesignLtd.Memberwti:LoanInvestmentsBiotechnologyMember2025-12-310001850938Mazen Animal Health Inc. | Senior Secured 2025-12-310001850938Ukko Inc. | Senior Secured 2025-12-310001850938wti:LoanInvestmentsBiotechnologyMember2025-12-310001850938Canary Connect, Inc. | Senior Secured2025-12-310001850938Proto, Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMember2025-12-310001850938D2C Store, Inc. | Senior Secured2025-12-310001850938Findigs, Inc. | Senior Secured2025-12-310001850938Giant Labs, Inc. | Senior Secured2025-12-310001850938Miami Labs, Inc. | Senior Secured2025-12-310001850938OneLocal, Inc. | Senior Secured2025-12-310001850938Quantcast Corp. | Senior Secured2025-12-310001850938Realm Living, Inc. | Senior Secured2025-12-310001850938RetailerX, Inc. | Senior Secured2025-12-310001850938Threedium, Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsInternetMember2025-12-310001850938Akadeum Life Sciences, Inc. | Senior Secured2025-12-310001850938eXo Imaging, Inc. | Senior Secured2025-12-310001850938Gallant Pet, Inc. | Senior Secured 12025-12-310001850938Gallant Pet, Inc. | Senior Secured 22025-12-310001850938Gallant Pet, Inc. | Senior Secured 32025-12-310001850938wti:GallantPetInc.Memberwti:LoanInvestmentsMedicalDevicesMember2025-12-310001850938wti:LoanInvestmentsMedicalDevicesMember2025-12-310001850938CarePoint | Senior Secured2025-12-310001850938Charlie Financial Inc. | Senior Secured 12025-12-310001850938Charlie Financial Inc. | Senior Secured 22025-12-310001850938wti:CharlieFinancialInc.Memberwti:LoanInvestmentsOtherHealthcareMember2025-12-310001850938GoForward, Inc. | Senior Secured2025-12-310001850938KBS, Inc. | Senior Secured2025-12-310001850938Lark Technologies, Inc. | Senior Secured2025-12-310001850938Modern Animal, Inc. | Senior Secured2025-12-310001850938Open Inc. | Senior Secured 12025-12-310001850938Open Inc. | Senior Secured 22025-12-310001850938wti:OpenIncMemberwti:LoanInvestmentsOtherHealthcareMember2025-12-310001850938Vitable, Inc. | Senior Secured2025-12-310001850938Yuva Biosciences, Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMember2025-12-310001850938AI Tech Holdings, Inc. | Senior Secured2025-12-310001850938American Castanea PBC | Senior Secured 12025-12-310001850938American Castanea PBC | Senior Secured 22025-12-310001850938wti:AmericanCastaneaPBCMemberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Azumo, Inc. | Senior Secured2025-12-310001850938Badiani Limited | Senior Secured2025-12-310001850938Belong, Inc. | Senior Secured 12025-12-310001850938Belong, Inc. | Senior Secured 22025-12-310001850938wti:BelongInc.Memberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Bryte, Inc. | Senior Secured2025-12-310001850938Carbon Ridge, Inc. | Senior Secured 12025-12-310001850938Carbon Ridge, Inc. | Senior Secured 22025-12-310001850938wti:CarbonRidgeInc.Memberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Cella Farms Inc. | Senior Secured2025-12-310001850938Coffee.ai Inc. | Senior Secured2025-12-310001850938CornerUp, Inc. | Senior Secured2025-12-310001850938Creoate Limited | Senior Secured 12025-12-310001850938Creoate Limited | Senior Secured 22025-12-310001850938Creoate Limited | Senior Secured 32025-12-310001850938Creoate Limited | Senior Secured 42025-12-310001850938Creoate Limited | Senior Secured 52025-12-310001850938Creoate Limited | Senior Secured 62025-12-310001850938Creoate Limited | Senior Secured 72025-12-310001850938Creoate Limited | Senior Secured 82025-12-310001850938Creoate Limited | Senior Secured 92025-12-310001850938Creoate Limited | Senior Secured 102025-12-310001850938Creoate Limited | Senior Secured 112025-12-310001850938Creoate Limited | Senior Secured 122025-12-310001850938Creoate Limited | Senior Secured 132025-12-310001850938Creoate Limited | Senior Secured 142025-12-310001850938Creoate Limited | Senior Secured 152025-12-310001850938Creoate Limited | Senior Secured 162025-12-310001850938Creoate Limited | Senior Secured 172025-12-310001850938Creoate Limited | Senior Secured 182025-12-310001850938wti:CreoateLimitedMemberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Daisyco, Inc. | Senior Secured2025-12-310001850938Eguana Technologies, Inc. | Senior Secured2025-12-310001850938Fanimal, Inc. | Senior Secured2025-12-310001850938Fortull, Inc. | Senior Secured2025-12-310001850938Gold Words, LLC | Senior Secured2025-12-310001850938Heading Health Inc. | Senior Secured2025-12-310001850938High Definition Vehicle Insurance, Inc. | Senior Secured2025-12-310001850938Higher Ground Education, Inc. | Senior Secured2025-12-310001850938Hint, Inc. | Senior Secured2025-12-310001850938Holo, Inc. | Senior Secured2025-12-310001850938Innventure LLC | Senior Secured2025-12-310001850938Joy Memories, Inc | Senior Secured2025-12-310001850938Kindred Motorworks, Inc. | Senior Secured2025-12-310001850938Last Energy Inc. | Senior Secured2025-12-310001850938LendTable Inc. | Senior Secured2025-12-310001850938Logistech Solutions Pte. Ltd. | Senior Secured2025-12-310001850938Mavenform, Inc. | Senior Secured2025-12-310001850938Merlin Labs, Inc. | Senior Secured2025-12-310001850938NewGlobe Education, Inc. | Senior Secured2025-12-310001850938Overdrive Products Inc. | Senior Secured2025-12-310001850938Owlet Baby Care, Inc. | Senior Secured2025-12-310001850938Plant Prefab, Inc. | Senior Secured2025-12-310001850938Ripple Foods, PBC | Senior Secured2025-12-310001850938Rise Gardens, Inc. | Senior Secured2025-12-310001850938Romaine Empire, Inc. | Senior Secured2025-12-310001850938Runzy, Inc. | Senior Secured2025-12-310001850938Scripta Insights, Inc. | Senior Secured2025-12-310001850938Sun Day Carwash, Inc. | Senior Secured 12025-12-310001850938Sun Day Carwash, Inc. | Senior Secured 22025-12-310001850938wti:SunDayCarwashIncMemberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Supplant, Inc. | Senior Secured2025-12-310001850938TheSquareFoot, Inc. | Senior Secured2025-12-310001850938TomoCredit, Inc. | Senior Secured2025-12-310001850938Umbra Lab, Inc. | Senior Secured 12025-12-310001850938Umbra Lab, Inc. | Senior Secured 22025-12-310001850938Umbra Lab, Inc. | Senior Secured 32025-12-310001850938wti:UmbraLabIncMemberwti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938World Wrapps II, Inc. | Senior Secured2025-12-310001850938Zeno Technologies, Inc. | Senior Secured2025-12-310001850938Zimeno Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMember2025-12-310001850938Terradepth, Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMember2025-12-310001850938Abacum Inc. | Senior Secured 12025-12-310001850938Abacum Inc. | Senior Secured 22025-12-310001850938wti:AbacumInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938APIsecAI, Inc. | Senior Secured 12025-12-310001850938APIsecAI, Inc. | Senior Secured 22025-12-310001850938wti:APIsecAIInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Bito Inc. | Senior Secured2025-12-310001850938Blackcart, Inc. | Senior Secured2025-12-310001850938Bloomboard, Inc. | Senior Secured2025-12-310001850938BlueCart, Inc. | Senior Secured2025-12-310001850938Bound Rates, Inc. | Senior Secured2025-12-310001850938Common Sun, Inc | Senior Secured 12025-12-310001850938Common Sun, Inc | Senior Secured 22025-12-310001850938wti:CommonSunIncMemberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Confirm HR, Inc. | Senior Secured2025-12-310001850938Crowded Technologies, Inc. | Senior Secured 12025-12-310001850938Crowded Technologies, Inc. | Senior Secured 22025-12-310001850938wti:CrowdedTechnologiesInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Eskalera, Inc. | Senior Secured2025-12-310001850938Family First, Inc | Senior Secured2025-12-310001850938Form Remodel, Inc. | Senior Secured2025-12-310001850938FutureProof Technologies, Inc. | Senior Secured2025-12-310001850938Grokker, Inc. | Senior Secured2025-12-310001850938Hoken Holdings Inc. | Senior Secured2025-12-310001850938Ioogo Inc. | Senior Secured2025-12-310001850938Ketch Kloud, Inc. | Senior Secured2025-12-310001850938Kolors, Inc. | Senior Secured 12025-12-310001850938Kolors, Inc. | Senior Secured 22025-12-310001850938wti:KolorsInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Kushki Group Holdings Ltd. | Senior Secured2025-12-310001850938Manifold Inc. | Senior Secured 12025-12-310001850938Manifold Inc. | Senior Secured 22025-12-310001850938wti:ManifoldInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Merlyn Mind, Inc. | Senior Secured2025-12-310001850938Migo Money, Inc. | Senior Secured2025-12-310001850938Parkoursc, Inc. | Senior Secured 12025-12-310001850938Parkoursc, Inc. | Senior Secured 22025-12-310001850938Parkoursc, Inc. | Senior Secured 32025-12-310001850938wti:ParkourscInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Safe Securities Inc. | Senior Secured 12025-12-310001850938Safe Securities Inc. | Senior Secured 22025-12-310001850938Safe Securities Inc. | Senior Secured 32025-12-310001850938Safe Securities Inc. | Senior Secured 42025-12-310001850938wti:SafeSecuritiesIncMemberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Semsee Corp. | Senior Secured2025-12-310001850938Standard Dental OpCo, Inc. | Senior Secured 12025-12-310001850938Standard Dental OpCo, Inc. | Senior Secured 22025-12-310001850938wti:StandardDentalOpCoInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Traction Apps, Inc. | Senior Secured2025-12-310001850938Truepic Inc. | Senior Secured 12025-12-310001850938Truepic Inc. | Senior Secured 22025-12-310001850938wti:TruepicInc.Memberwti:LoanInvestmentsSoftwareMember2025-12-310001850938Vesta Housing, Inc. | Senior Secured 12025-12-310001850938Vesta Housing, Inc. | Senior Secured 22025-12-310001850938Vesta Housing, Inc. | Senior Secured 32025-12-310001850938Vesta Housing, Inc. | Senior Secured 42025-12-310001850938Vesta Housing, Inc. | Senior Secured 52025-12-310001850938wti:VestaHousingIncMemberwti:LoanInvestmentsSoftwareMember2025-12-310001850938ZeroCater, Inc. | Senior Secured2025-12-310001850938wti:LoanInvestmentsSoftwareMember2025-12-310001850938Ava Finance, Inc. | Senior Secured 12025-12-310001850938Ava Finance, Inc. | Senior Secured 22025-12-310001850938Ava Finance, Inc. | Senior Secured 32025-12-310001850938Ava Finance, Inc. | Senior Secured 42025-12-310001850938Ava Finance, Inc. | Senior Secured 52025-12-310001850938Ava Finance, Inc. | Senior Secured 62025-12-310001850938Ava Finance, Inc. | Senior Secured 72025-12-310001850938wti:AvaFinanceIncMemberwti:LoanInvestmentsTechnologyServicesMember2025-12-310001850938Klar Holdings Limited | Senior Secured 12025-12-310001850938Klar Holdings Limited | Senior Secured 22025-12-310001850938Klar Holdings Limited | Senior Secured 32025-12-310001850938wti:KlarHoldingsLimitedMemberwti:LoanInvestmentsTechnologyServicesMember2025-12-310001850938Loansnap Holdings Inc. | Senior Secured2025-12-310001850938MAYD Group GmbH | Senior Secured2025-12-310001850938Prima Holdings Limited | Senior Secured2025-12-310001850938Surround Group, Inc. | Senior Secured2025-12-310001850938Techspert.IO Limited | Senior Secured2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMember2025-12-310001850938Juvo Mobile, Inc. | Senior Secured2025-12-310001850938Nextivity, Inc. | Senior Secured 12025-12-310001850938Nextivity, Inc. | Senior Secured 22025-12-310001850938Nextivity, Inc. | Senior Secured 32025-12-310001850938wti:NextivityInc.Memberwti:LoanInvestmentsWirelessMember2025-12-310001850938wti:LoanInvestmentsWirelessMember2025-12-310001850938srt:MaximumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate530FloorRate230Maturity12312025Member2025-12-310001850938srt:MinimumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate530FloorRate230Maturity12312025Member2025-12-310001850938wti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate530FloorRate230Maturity12312025Member2025-12-310001850938srt:MaximumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2025-12-310001850938srt:MinimumMemberwti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2025-12-310001850938wti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate5.30FloorRate3.24Maturity12312026Member2025-12-310001850938wti:ZionsBancorporationNAMemberwti:InterestRateCollarCapRate4.00FloorRate2.90Maturity12312027Member2025-12-310001850938wti:InterestRateCollarMember2025-12-310001850938wti:WTIFundXIncMemberwti:WTIFundXLLCMember2026-01-012026-06-300001850938wti:WTIFundXLLCMember2020-10-012020-10-310001850938wti:WTIFundXLLCMember2020-10-310001850938wti:PerformingLoansMembersrt:WeightedAverageMember2026-04-012026-06-300001850938wti:PerformingLoansMembersrt:WeightedAverageMember2025-04-012025-06-300001850938wti:PerformingLoansMembersrt:WeightedAverageMember2026-01-012026-06-300001850938wti:PerformingLoansMembersrt:WeightedAverageMember2025-01-012025-06-300001850938srt:WeightedAverageMember2026-04-012026-06-300001850938srt:WeightedAverageMember2025-04-012025-06-300001850938srt:WeightedAverageMember2026-01-012026-06-300001850938srt:WeightedAverageMember2025-01-012025-06-300001850938wti:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2026-06-300001850938wti:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2026-06-300001850938us-gaap:FairValueInputsLevel3Member2026-06-300001850938wti:LoanInvestmentsBiotechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsBiotechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsComputersAndStorageMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsInternetMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsInternetMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsMedicalDevicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsMedicalDevicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsOtherHealthcareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsOtherTechnologyMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSemiconductorsAndEquipmentMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsSoftwareMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisAndAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsTechnologyServicesMemberwti:MeasurementInputProbabilityWeightingOfAlternativeOutcomesMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationAssetRecoveryMember2025-12-310001850938wti:LoanInvestmentsWirelessMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938wti:LoanInvestmentsWirelessMemberwti:MeasurementInputMostAdvantageousEffectiveYieldRateMembersrt:WeightedAverageMemberus-gaap:FairValueInputsLevel3Memberwti:ValuationMostAdvantageousMarketAnalysisMember2025-12-310001850938us-gaap:FairValueInputsLevel3Member2025-12-310001850938us-gaap:FairValueInputsLevel1Member2026-06-300001850938us-gaap:FairValueInputsLevel2Member2026-06-300001850938us-gaap:FairValueInputsLevel1Member2025-12-310001850938us-gaap:FairValueInputsLevel2Member2025-12-310001850938us-gaap:LoansMember2026-03-310001850938us-gaap:WarrantMember2026-03-310001850938us-gaap:LoansMember2026-04-012026-06-300001850938us-gaap:WarrantMember2026-04-012026-06-300001850938us-gaap:DebtAndEquitySecuritiesRealizedGainLossus-gaap:LoansMember2026-04-012026-06-300001850938us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossus-gaap:LoansMember2026-04-012026-06-300001850938us-gaap:LoansMember2026-06-300001850938us-gaap:WarrantMember2026-06-300001850938us-gaap:LoansMember2025-12-310001850938us-gaap:WarrantMember2025-12-310001850938us-gaap:LoansMember2026-01-012026-06-300001850938us-gaap:WarrantMember2026-01-012026-06-300001850938us-gaap:DebtAndEquitySecuritiesRealizedGainLossus-gaap:LoansMember2026-01-012026-06-300001850938us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossus-gaap:LoansMember2026-01-012026-06-300001850938us-gaap:LoansMember2025-03-310001850938us-gaap:WarrantMember2025-03-310001850938wti:ConvertibleNotesMember2025-03-310001850938us-gaap:LoansMember2025-04-012025-06-300001850938us-gaap:WarrantMember2025-04-012025-06-300001850938wti:ConvertibleNotesMember2025-04-012025-06-300001850938us-gaap:DebtAndEquitySecuritiesRealizedGainLossus-gaap:LoansMember2025-04-012025-06-300001850938us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossus-gaap:LoansMember2025-04-012025-06-300001850938us-gaap:LoansMember2025-06-300001850938us-gaap:WarrantMember2025-06-300001850938wti:ConvertibleNotesMember2025-06-300001850938us-gaap:LoansMember2024-12-310001850938us-gaap:WarrantMember2024-12-310001850938wti:ConvertibleNotesMember2024-12-310001850938us-gaap:LoansMember2025-01-012025-06-300001850938us-gaap:WarrantMember2025-01-012025-06-300001850938wti:ConvertibleNotesMember2025-01-012025-06-300001850938us-gaap:DebtAndEquitySecuritiesRealizedGainLossus-gaap:LoansMember2025-01-012025-06-300001850938us-gaap:DebtAndEquitySecuritiesUnrealizedGainLossus-gaap:LoansMember2025-01-012025-06-3000018509382025-01-012025-12-310001850938wti:WTIFundXLLCMember2026-06-300001850938wti:WTIFundXLLCMember2025-12-310001850938wti:CashDividendDistributionMember2026-01-012026-06-300001850938wti:CashDividendDistributionMember2025-01-012025-06-300001850938wti:EquityDividendDistributionMember2026-01-012026-06-300001850938wti:EquityDividendDistributionMember2025-01-012025-06-300001850938us-gaap:RevolvingCreditFacilityMemberwti:LoanAgreementMember2026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentOneMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentTwoMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberwti:VariableRateComponentThreeMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2026-01-012026-06-300001850938us-gaap:LineOfCreditMemberwti:LoanAgreementMemberus-gaap:RevolvingCreditFacilityMember2025-12-310001850938wti:ManagementFeePeriodOneMember2026-01-012026-06-300001850938wti:ManagementFeePeriodTwoMember2026-01-012026-06-300001850938wti:ManagementFeePeriodThreeMember2026-01-012026-06-300001850938wti:ManagementFeePeriodFourMember2026-01-012026-06-300001850938wti:ManagementFeePeriodFiveMember2026-01-012026-06-300001850938wti:ManagementFeePeriodSixMember2026-01-012026-06-300001850938wti:ManagementFeePeriodSevenMember2026-01-012026-06-300001850938wti:ManagementFeePeriodEightMember2026-01-012026-06-300001850938wti:ManagementFeePeriodNineMember2026-01-012026-06-300001850938wti:ManagementFeePeriodNineMember2026-06-300001850938wti:InterestRateCollarMember2026-04-012026-06-300001850938wti:InterestRateCollarMember2025-04-012025-06-300001850938wti:InterestRateCollarMember2026-01-012026-06-300001850938wti:InterestRateCollarMember2025-01-012025-06-300001850938wti:ZionsBancorporationNAMember2026-06-300001850938wti:ZionsBancorporationNAMember2025-12-310001850938Abacum Inc. | Software2026-06-300001850938Belong, Inc. | Other Technology2026-06-300001850938Cofertility, Inc. | Other Technology2026-06-300001850938Crowded Technologies, Inc. | Software2026-06-300001850938eXo Imaging, Inc. | Medical Devices2026-06-300001850938Fortull, Inc. | Other Technology2026-06-300001850938Global Publishing Interactive, Inc. | Software2026-06-300001850938GoForward, Inc. | Other Healthcare2026-06-300001850938Jericho Security, Inc. | Software2026-06-300001850938Lucra Inc. | Software2026-06-300001850938Merlyn Mind, Inc. | Software2026-06-300001850938Orion Longevity, Inc. | Other Technology2026-06-300001850938Outbuild Technologies, Inc. | Software2026-06-300001850938Pioneers Educaton, Inc. | Other Technology2026-06-300001850938Safe Securities Inc. | Software2026-06-300001850938Slice Solutions, Inc. | Internet2026-06-300001850938Workspot, Inc. | Software2026-06-300001850938World View Enterprises Inc. | Other Technology2026-06-300001850938Abacum Inc. | Software2025-12-310001850938Ava Finance, Inc. | Technology Services2025-12-310001850938Bito Inc. | Software2025-12-310001850938Creoate Limited | Other Technology2025-12-310001850938Crowded Technologies, Inc. | Software2025-12-310001850938Daisyco, Inc. | Other Technology2025-12-310001850938eXo Imaging, Inc. | Medical Devices2025-12-310001850938Fortull, Inc. | Other Technology2025-12-310001850938GoForward, Inc. | Other Healthcare2025-12-310001850938Lark Technologies, Inc. | Other Healthcare2025-12-310001850938Prima Holdings Limited | Technology Services2025-12-310001850938Safe Securities Inc. | Software2025-12-310001850938Teiko Bio, Inc. | Biotechnology2025-12-310001850938Vitable, Inc. | Other Healthcare2025-12-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

[X]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2026

[  ]TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ______________

Commission file number 814-01414

WTI Fund X, Inc.
(Exact Name of Registrant as specified in its charter)
Maryland85-3539868
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
104 La Mesa Drive, Suite 102, Portola Valley, CA
94028
(Address of principal executive offices)(Zip Code)

(650) 234-4300
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x]  No [ ]

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [x ]   No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer [ ]Accelerated filer [ ]
Non-accelerated filer [x]
Smaller reporting company [ ]
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [ ] No [x]
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
ClassOutstanding as of August 13, 2026
Common Stock, $0.001 par value100,000




WTI FUND X, INC.
INDEX
PART I — FINANCIAL INFORMATION
Item 1.Financial Statements
Condensed Statements of Assets and Liabilities (Unaudited)
As of June 30, 2026 and December 31, 2025
Condensed Statements of Operations (Unaudited)
For the three and six months ended June 30, 2026 and 2025
Condensed Statements of Changes in Net Assets (Unaudited)
For the three and six months ended June 30, 2026 and 2025
Condensed Statements of Cash Flows (Unaudited)
For the six months ended June 30, 2026 and 2025
Condensed Schedules of Investments (Unaudited)
As of June 30, 2026 and December 31, 2025
Notes to Condensed Financial Statements (Unaudited)
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3.Quantitative and Qualitative Disclosures About Market Risk
Item 4.Controls and Procedures
PART II — OTHER INFORMATION
Item 1.Legal Proceedings
Item 1A.Risk Factors
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.Defaults Upon Senior Securities
Item 4.Mine Safety Disclosures
Item 5.Other Information
Item 6.Exhibits
SIGNATURES





PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

WTI FUND X, INC.

CONDENSED STATEMENTS OF ASSETS AND LIABILITIES (UNAUDITED)
AS OF JUNE 30, 2026 AND DECEMBER 31, 2025

June 30, 2026December 31, 2025
ASSETS
Loans, at estimated fair value
   (amortized cost of $361,596,615 and $430,925,365, respectively)
$324,437,972 $398,113,300 
Derivative asset
132,744 — 
Cash
16,175,832 24,221,249 
Dividend and interest receivables4,391,409 6,270,312 
Other assets942,630 852,611 
Total assets346,080,587 429,457,472 
LIABILITIES
Borrowings under debt facility128,000,000 232,500,000 
Accrued management fees1,562,500 1,562,500 
Derivative liability1,468 149,057 
Accounts payable and other accrued liabilities1,569,442 2,213,565 
Total liabilities131,133,410 236,425,122 
NET ASSETS$214,947,177 $193,032,350 
Analysis of Net Assets:
Capital paid in on shares of capital stock$384,000,000 $358,000,000 
Cumulative return of capital distributions(132,019,639)(130,763,657)
Total distributable losses(37,033,184)(34,203,993)
Net assets (equivalent to $2,149.47 and $1,930.32 per share based on 100,000 shares of capital stock outstanding - see Notes 5 and 11)
$214,947,177 $193,032,350 
Commitments & Contingent Liabilities:
Unexpired unfunded commitments (see Note 9)$85,750,000 $82,500,000 











See notes to condensed financial statements (unaudited).
3


WTI FUND X, INC.

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025

For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
INVESTMENT INCOME:
Interest on loans$18,266,838 $19,991,231 $46,203,918 $36,772,075 
        Other income67,429 1,034,669 101,905 1,265,569 
Total investment income18,334,267 21,025,900 46,305,823 38,037,644 
EXPENSES:
Management fees1,562,500 1,875,000 3,125,000 3,750,000 
Interest expense2,666,695 3,862,968 5,926,122 7,902,775 
Banking and professional fees139,735 210,237 211,888 530,322 
Other operating expenses41,841 79,994 147,646 120,326 
Total expenses4,410,771 6,028,199 9,410,656 12,303,423 
Net investment income 13,923,496 14,997,701 36,895,167 25,734,221 
Net realized loss from loans(205,616)(101,895)(1,407,968)(101,895)
Net change in unrealized loss from loans(2,077,761)(1,659,758)(4,346,578)(9,330,440)
Net change in unrealized gain (loss) from derivative instruments125,529 (3,607)280,333 (103,780)
Net realized and change in unrealized loss from loans and derivative instruments
(2,157,848)(1,765,260)(5,474,213)(9,536,115)
Net increase in net assets resulting from operations$11,765,648 $13,232,441 $31,420,954 $16,198,106 
Amounts per common share:
Net increase in net assets resulting from operations per share$117.66 $132.32 $314.21 $161.98 
Weighted average shares outstanding100,000 100,000 100,000 100,000 


















See notes to condensed financial statements (unaudited).

4


WTI FUND X, INC.

CONDENSED STATEMENTS OF CHANGES IN NET ASSETS (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025
Common Stock
SharesPar ValueAdditional Paid-in CapitalReturn of Capital DistributionsTotal Distributable LossesNet Assets
Balance at March 31, 2025100,000 $100 $357,999,900 $(80,420,780)$(35,832,473)$241,746,747 
Net increase in net assets resulting from operations— — — — 13,232,441 13,232,441 
Distributions of income to shareholder— — — — (14,895,806)(14,895,806)
Return of capital to shareholder— — — (14,767,256)— (14,767,256)
Balance at June 30, 2025
100,000 $100 $357,999,900 $(95,188,036)$(37,495,838)$225,316,126 
Balance at March 31, 2026100,000 $100 $357,999,900 $(132,019,639)$(36,318,007)$189,662,354 
Net increase in net assets resulting from operations— — — — 11,765,648 11,765,648 
Distributions of income to shareholder— — — — (12,480,825)(12,480,825)
Contributions from shareholder— — 26,000,000 — — 26,000,000 
Balance at June 30, 2026
100,000 $100 $383,999,900 $(132,019,639)$(37,033,184)$214,947,177 
Balance at December 31, 2024
100,000 $100 $335,999,900 $(77,592,923)$(28,061,618)$230,345,459 
Net increase in net assets resulting from operations— — — — 16,198,106 16,198,106 
Distributions of income to shareholder— — — — (25,632,326)(25,632,326)
Return of capital to shareholder— — — (17,595,113)— (17,595,113)
Contributions from shareholder— — 22,000,000 — — 22,000,000 
Balance at June 30, 2025
100,000 $100 $357,999,900 $(95,188,036)$(37,495,838)$225,316,126 
Balance at December 31, 2025
100,000 $100 $357,999,900 $(130,763,657)$(34,203,993)$193,032,350 
Net increase in net assets resulting from operations— — — — 31,420,954 31,420,954 
Distributions of income to shareholder— — — — (34,250,145)(34,250,145)
Return of capital to shareholder— — — (1,255,982)— (1,255,982)
Contributions from shareholder— — 26,000,000 — — 26,000,000 
Balance at June 30, 2026
100,000 $100 $383,999,900 $(132,019,639)$(37,033,184)$214,947,177 














See notes to condensed financial statements (unaudited).
5


WTI FUND X, INC.

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net increase in net assets resulting from operations$31,420,954 $16,198,106 
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by operating activities:
Net realized loss from loans1,407,968 101,895 
Net change in unrealized loss from loans4,346,578 9,330,440 
Net change in unrealized gain (loss) from derivative instruments
(280,333)103,780 
Amortization of deferred costs related to debt facility221,073 221,073 
Origination of loans(65,350,000)(60,487,000)
Principal payments on loans, net of accretion131,149,812 60,452,689 
Acquisition of equity securities(6,385,157)(6,726,268)
Changes in operating assets and liabilities:
Net decrease in dividend and interest receivables1,878,903 532,156 
Net (increase) decrease in other assets(311,092)126,821 
Net decrease in accounts payable, other accrued liabilities and accrued management fees(644,123)(138,014)
Net cash provided by operating activities97,454,583 19,715,678 
CASH FLOWS FROM FINANCING ACTIVITIES:
Cash distributions to shareholder(27,000,000)(31,700,000)
Contributions from shareholder26,000,000 22,000,000 
Borrowings under debt facility— 7,000,000 
Repayments of borrowings under debt facility(104,500,000)(32,000,000)
Net cash used in financing activities(105,500,000)(34,700,000)
 Net decrease in cash and cash equivalents(8,045,417)(14,984,322)
CASH AND CASH EQUIVALENTS:
Beginning of period24,221,249 25,245,995 
End of period$16,175,832 $10,261,673 
SUPPLEMENTAL DISCLOSURES:
CASH PAID DURING THE PERIOD:   
Interest - Debt facility$6,191,714 $7,731,234 
NON-CASH OPERATING AND FINANCING ACTIVITIES:   
Distributions of equity securities to shareholder$8,506,127 $11,527,439 
Receipt of equity securities as repayment of loans$2,120,970 $4,801,171 


See notes to condensed financial statements (unaudited).

6



WTI FUND X, INC.

CONDENSED SCHEDULE OF INVESTMENTS (UNAUDITED)
AS OF JUNE 30, 2026


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Biotechnology
Biolojic Design Ltd. ** ^Senior Secured12.5%$10,574,925 $10,087,058 $10,087,058 6/1/2029
Mazen Animal Health Inc.Senior Secured14.3%3,145,079 3,059,863 2,107,972 *
Teiko Bio, Inc.Senior Secured12.5%750,000 678,865 678,865 5/1/2029
Teiko Bio, Inc.Senior Secured12.5%750,000 729,228 729,228 10/1/2029
Teiko Bio, Inc. Subtotal12.5%1,500,000 1,408,093 1,408,093 
Biotechnology Total6.3%$15,220,004 $14,555,014 $13,603,123 
Computers & Storage
Proto, Inc.Senior Secured13.0%17.8%$641,161 $633,589 $633,589 7/1/2028
Computers & Storage Total0.3%$641,161 $633,589 $633,589 
Internet
BossBites Inc.Senior Secured12.0%$1,500,000 $1,431,785 $1,431,785 4/1/2029
D2C Store, Inc.Senior Secured10.0%669,717 535,312 535,312 1/1/2027
Findigs, Inc.Senior Secured13.5%1,662,956 1,623,938 1,623,938 7/1/2027
OneLocal, Inc. ** ^Senior Secured12.3%16,268 16,163 16,163 7/1/2026
Quantcast Corp.Senior Secured12.0%5,963,573 3,634,951 5,857,049 *
Realm Living, Inc.Senior Secured15.7%2,180,728 1,923,574 1,923,574 3/1/2029
RetailerX, Inc.Senior Secured11.0%7,188,763 6,483,557 6,011,653 *
Slice Solutions, Inc.Senior Secured11.0%5,000,000 4,586,152 4,586,152 5/1/2031
Threedium, Inc. ** ^Senior Secured13.3%639,542 580,424 580,424 12/1/2027
Internet Total10.5%$24,821,547 $20,815,856 $22,566,050 
Medical Devices
Akadeum Life Sciences, Inc.Senior Secured14.3%$1,301,593 $1,209,338 $1,209,338 9/1/2027
eXo Imaging, Inc.Senior Secured12.5%3,750,000 3,346,011 3,346,011 12/1/2028
Gallant Pet, Inc.Senior Secured13.3%1,491,239 1,397,877 1,397,877 5/1/2028
Gallant Pet, Inc.Senior Secured14.0%309,160 304,849 304,849 10/1/2026
Gallant Pet, Inc.Senior Secured13.0%894,159 894,158 894,158 5/1/2028
Gallant Pet, Inc. Subtotal2,694,558 2,596,884 2,596,884 
Medical Devices Total3.3%$7,746,151 $7,152,233 $7,152,233 
Other Healthcare
Charlie Financial Inc.Senior Secured10.0%$7,000,000 $6,820,782 $— *
GoForward, Inc.Senior Secured12.8%20,444,754 18,298,517 9,169,522 *
Lark Technologies, Inc.Senior Secured13.5%8,612,554 7,298,202 7,298,202 4/1/2028
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.5%1,500,000 1,503,908 1,503,908 11/1/2029
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.6%2,000,000 1,987,167 1,987,167 1/1/2030
MeMed Diagnostics Ltd. ** ^Senior Secured11.0%7.6%1,500,000 1,180,153 1,180,153 10/1/2029
MeMed Diagnostics Ltd. ** ^ Subtotal5,000,000 4,671,228 4,671,228 
Vitable, Inc.Senior Secured13.0%4,500,000 4,306,597 4,306,597 4/1/2029
Vitable, Inc.Senior Secured13.0%3,000,000 2,952,972 2,952,972 4/1/2029
Vitable, Inc. Subtotal7,500,000 7,259,569 7,259,569 
Other Healthcare Total13.2%$48,557,308 $44,348,298 $28,398,521 
7


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Other Technology
AI Tech Holdings, Inc.Senior Secured12.0%$454,471 $423,225 $423,225 10/1/2028
Allocate Holdings Inc.Senior Secured10.5%5,500,000 5,234,910 5,234,910 7/1/2031
American Castanea PBCSenior Secured11.8%
6.7%
541,757 557,433 557,433 10/1/2028
American Castanea PBCSenior Secured11.8%6.7%158,787 24,312 24,312 12/1/2027
American Castanea PBC Subtotal700,544 581,745 581,745 
Azumo, Inc.Senior Secured12.8%957,356 913,213 453,370 *
Badiani Limited ** ^Senior Secured13.6%1,970,775 1,492,643 1,056,073 *
Belong, Inc.Senior Secured13.5%1,500,000 1,139,554 1,139,554 3/1/2029
Belong, Inc.Senior Secured13.5%750,000 673,544 673,544 3/1/2029
Belong, Inc.Senior Secured13.0%625,000 512,237 512,237 3/1/2029
Belong, Inc. Subtotal2,875,000 2,325,335 2,325,335 
Brick Dynamics Inc.Senior Secured12.0%500,000 486,342 486,342 7/1/2029
Brick Dynamics Inc.Senior Secured12.0%500,000 465,747 465,747 4/1/2029
Brick Dynamics Inc. Subtotal1,000,000 952,089 952,089 
Bryte, Inc.Senior Secured10.0%1,694,943 1,708,964 1,003,561 *
Carbon Ridge, Inc.Senior Secured12.5%1,067,389 1,030,273 1,030,273 1/1/2029
Carbon Ridge, Inc.Senior Secured12.5%886,849 836,308 836,308 7/1/2028
Carbon Ridge, Inc. Subtotal1,954,238 1,866,581 1,866,581 
Cella Farms Inc.Senior Secured11.8%1,456,621 1,422,963 — *
Cofertility, Inc.Senior Secured11.8%750,000 637,793 637,793 8/1/2029
Coffee.ai Inc.Senior Secured11.0%1,101,447 954,155 768,872 12/1/2028
CornerUp, Inc.Senior Secured15.0%392,046 359,248 — *
Creoate Limited ** ^Senior Secured12.8%375,000 366,613 366,613 8/1/2029
Creoate Limited ** ^Senior Secured12.8%750,000 734,044 734,044 7/1/2029
Creoate Limited ** ^Senior Secured12.8%1,125,000 1,058,100 1,058,100 5/1/2029
Creoate Limited ** ^Senior Secured12.8%327,914 239,267 239,267 4/1/2028
Creoate Limited ** ^Senior Secured12.8%371,047 368,638 368,638 6/1/2028
Creoate Limited ** ^Senior Secured12.8%475,190 472,082 472,082 5/1/2028
Creoate Limited ** ^Senior Secured12.8%484,680 480,670 480,670 12/1/2028
Creoate Limited ** ^Senior Secured12.8%436,895 433,317 433,317 11/1/2028
Creoate Limited ** ^Senior Secured12.8%424,074 420,822 420,822 10/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0 %299,958 299,679 299,679 1/1/2028
Creoate Limited ** ^Senior Secured12.8%384,589 381,979 381,979 7/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0 %383,473 382,577 382,577 2/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0 %323,995 324,128 324,128 12/1/2027
Creoate Limited ** ^Senior Secured12.8%1.0 %413,490 414,417 414,417 11/1/2027
Creoate Limited ** ^Senior Secured12.8%132,208 131,309 131,309 8/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0 %334,708 335,984 335,984 10/1/2027
Creoate Limited ** ^Senior Secured12.8%1.0 %467,555 454,992 454,992 8/1/2027
Creoate Limited ** ^Senior Secured15.5%152,922 152,154 152,154 2/1/2027
Creoate Limited ** ^ Subtotal7,662,698 7,450,772 7,450,772 
Daisyco, Inc.Senior Secured10.8%3,750,000 3,512,683 3,512,683 4/1/2029
Eguana Technologies, Inc. ** ^Senior Secured12.0%3,107,383 2,762,836 1,165,629 *
Fanimal, Inc.Senior Secured11.8%547,646 474,726 — *
Fortull, Inc.Senior Secured11.0%375,000 362,378 362,378 4/1/2029
Fortull, Inc.Senior Secured11.0%375,000 327,059 327,059 1/1/2029
Fortull, Inc. Subtotal750,000 689,437 689,437 
Gold Words, LLCSenior Secured12.0%408,882 401,313 401,313 12/1/2027
Grin Technology Services Inc.Senior Secured12.0%1,000,000 887,804 887,804 10/1/2029
Heading Health Inc.Senior Secured12.5%832,673 693,563 91,717 *
High Definition Vehicle Insurance, Inc.Senior Secured14.5%6,889,719 6,750,684 6,750,684 4/1/2027
Higher Ground Education, Inc.Senior Secured15.0%23,257,401 14,465,427 19,367,243 *
Hint, Inc.Senior Secured13.8%3,989,029 3,139,288 3,139,288 1/1/2028
8


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Holo, Inc.Senior Secured13.5%204,304 26,811 26,811 *
Innventure LLC **Senior Secured13.5%12,391,281 7,140,450 7,140,450 6/1/2028
Joy Memories, IncSenior Secured12.8%1.5%4,000,000 3,259,455 3,259,455 1/1/2030
Joy Memories, IncSenior Secured12.0%3,334,948 3,513,167 3,513,167 6/1/2027
Joy Memories, Inc Subtotal7,334,948 6,772,622 6,772,622 
Kindred Motorworks, Inc.Senior Secured12.0%7,070,292 7,069,736 7,069,736 10/1/2028
LendTable Inc.Senior Secured14.1%2,414,807 2,291,370 — *
Logistech Solutions Pte. Ltd. ** ^Senior Secured12.1%304,525 282,449 282,449 3/1/2027
Mavenform, Inc.Senior Secured13.5%4,046,035 3,508,070 2,409,036 *
NewGlobe Education, Inc. ** ^Senior Secured12.5%15,569,449 15,814,711 15,814,711 4/1/2029
Overdrive Products Inc.Senior Secured13.5%336,131 281,147 281,147 1/1/2028
Plant Prefab, Inc.Senior Secured12.4%1,231,222 712,962 712,962 *
Ripple Foods, PBCSenior Secured12.0%8,049,693 7,981,225 7,981,225 6/1/2029
Rise Gardens, Inc.Senior Secured11.8%1,380,944 1,201,703 230,195 *
Romaine Empire, Inc.Senior Secured13.5%6,289,937 6,465,076 3,610,095 12/1/2027
Runzy, Inc.Senior Secured10.0%220,000 216,452 55,568 *
Scripta Insights, Inc.Senior Secured12.5%1,717,321 1,657,415 1,657,415 4/1/2028
Supplant, Inc. ** ^Senior Secured13.7%1,801,277 1,691,973 979,119 *
TheSquareFoot, Inc.Senior Secured18.0%623,478 320,058 — *
TomoCredit, Inc.Senior Secured13.8%1,117,297 1,103,308 1,103,308 4/1/2027
Umbra Lab, Inc.Senior Secured15.3%939,266 934,090 934,090 10/1/2026
Umbra Lab, Inc.Senior Secured12.5%18,050,000 17,083,341 17,083,341 10/1/2029
Umbra Lab, Inc.Senior Secured13.5%5,041,959 4,917,807 4,917,807 1/1/2028
Umbra Lab, Inc. Subtotal24,031,225 22,935,238 22,935,238 
World Wrapps II, Inc.Senior Secured12.5%806,398 779,604 779,604 1/1/2029
Zeno Technologies, Inc.Senior Secured10.0%251,129 233,996 — *
Other Technology Total64.5%$170,194,565 $148,587,773 $138,601,815 
Semiconductors & Equipment
D2S, Inc.Senior Secured13.5%$2,500,000 $2,217,953 $2,217,953 5/1/2029
Terradepth, Inc.Senior Secured12.5%3,567,644 3,474,795 3,474,795 9/1/2028
Semiconductors & Equipment Total2.6%$6,067,644 $5,692,748 $5,692,748 
Software
Abacum Inc.Senior Secured12.8%$1,191,431 $1,175,437 $1,175,437 5/1/2028
Abacum Inc.Senior Secured13.5%230,696 228,589 228,589 10/1/2026
Abacum Inc. Subtotal1,422,127 1,404,026 1,404,026 
APIsecAI, Inc.Senior Secured12.0%1,301,942 1,238,342 1,238,342 5/1/2028
APIsecAI, Inc.Senior Secured12.0%750,000 730,863 730,863 1/1/2029
APIsecAI, Inc. Subtotal2,051,942 1,969,205 1,969,205 
Bito Inc.Senior Secured12.5%750,000 655,930 655,930 5/1/2029
Bloomboard, Inc.Senior Secured12.0%4,333,940 4,063,605 4,063,605 3/1/2029
BlueCart, Inc.Senior Secured14.1%859,238 802,533 573,582 *
Bound Rates, Inc. ** ^Senior Secured13.0%958,217 928,954 928,954 12/1/2027
Canvas Medical, Inc.Senior Secured12.0%1,750,000 1,637,471 1,637,471 10/1/2029
Checksum AI, Inc.Senior Secured11.3%1,000,000 944,747 944,747 10/1/2029
Common Sun, IncSenior Secured11.0%110,676 110,676 110,676 1/1/2027
Common Sun, IncSenior Secured11.0%48,792 48,650 48,650 7/1/2026
Common Sun, Inc Subtotal159,468 159,326 159,326 
Crowded Technologies, Inc.Senior Secured12.5%562,500 547,096 547,096 1/1/2029
Crowded Technologies, Inc.Senior Secured12.5%562,500 481,369 481,369 12/1/2028
Crowded Technologies, Inc. Subtotal1,125,000 1,028,465 1,028,465 
Eskalera, Inc.Senior Secured12.0%1,231,088 1,193,618 477,603 *
9


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Evolver Transformation, Inc.Senior Secured11.5%5,000,000 4,588,795 4,588,795 6/1/2031
Family First, IncSenior Secured12.0%2,248,736 2,371,877 2,117,447 1/1/2028
Form Remodel, Inc.Senior Secured11.0%585,436 581,935 — *
Global Publishing Interactive, Inc.Senior Secured12.0%1,000,000 899,144 899,144 1/1/2030
Ioogo Inc.Senior Secured13.5%4,830,303 4,616,297 — *
Jericho Security, Inc.Senior Secured12.0%750,000 610,955 610,955 10/1/2029
Ketch Kloud, Inc.Senior Secured13.0%3,367,044 3,202,955 3,202,955 10/1/2027
Kolors, Inc. ** ^Senior Secured13.5%2.5%882,225 912,769 912,769 6/1/2027
Kolors, Inc. ** ^Senior Secured13.3%2.5%900,205 949,540 949,540 2/1/2027
Kolors, Inc. ** ^ Subtotal1,782,430 1,862,309 1,862,309 
Merlyn Mind, Inc.Senior Secured12.5%750,000 354,200 354,200 6/1/2030
Merlyn Mind, Inc.Senior Secured13.1%25,953,021 22,123,337 22,123,337 1/1/2029
Merlyn Mind, Inc.Senior Secured12.5%1,750,000 821,338 821,338 7/1/2030
Merlyn Mind, Inc. Subtotal28,453,021 23,298,875 23,298,875 
Migo Money, Inc. ** ^Senior Secured11.5%1,210,106 1,206,863 503,219 *
Outbuild Technologies, Inc.Senior Secured12.0%1,675,000 1,598,882 1,598,882 3/1/2029
Parkoursc, Inc.Senior Secured12.9%2,703,223 2,515,297 2,515,297 9/1/2028
Safe Securities Inc.Senior Secured12.3%1.0%1,471,024 1,442,720 1,442,720 10/1/2027
Safe Securities Inc.Senior Secured11.5%1.0%4,029,455 3,649,877 3,649,877 5/1/2029
Safe Securities Inc.Senior Secured12.3%1.0%1,961,366 1,966,904 1,966,904 10/1/2027
Safe Securities Inc.Senior Secured12.3%1.0%1,471,024 1,482,073 1,482,073 10/1/2027
Safe Securities Inc. Subtotal8,932,869 8,541,574 8,541,574 
Traction Apps, Inc. ** ^Senior Secured12.0%603,216 443,503 408,306 *
Truepic Inc.Senior Secured12.3%1,189,866 1,167,101 1,167,101 5/1/2028
Truepic Inc.Senior Secured12.3%477,462 422,364 422,364 12/1/2027
Truepic Inc. Subtotal1,667,328 1,589,465 1,589,465 
Vesta Housing, Inc.Senior Secured14.8%6,356,377 6,432,020 6,432,020 *
Workspot, Inc.Senior Secured11.8%500,000 416,370 416,370 6/1/2029
ZeroCater, Inc.Senior Secured12.5%4,111,535 4,024,353 4,024,353 4/1/2028
Software Total35.6%$91,417,644 $83,589,349 $76,452,880 
Technology Services
Ava Finance, Inc.Senior Secured10.8%1.5%$728,260 $718,830 $718,830 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 740,075 740,075 1/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 741,200 741,200 12/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%364,130 360,967 360,967 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 742,311 742,311 10/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 739,319 739,319 2/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%683,953 586,702 586,702 9/1/2028
Ava Finance, Inc. Subtotal4,776,343 4,629,404 4,629,404 
Klar Holdings Limited ** ^Senior Secured12.5%2,745,557 2,558,049 2,558,049 3/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%2,976,623 2,939,053 2,939,053 5/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%2,862,201 2,827,563 2,827,563 4/1/2028
Klar Holdings Limited ** ^ Subtotal8,584,381 8,324,665 8,324,665 
Loansnap Holdings Inc. **Senior Secured10.3%3,669,060 3,485,045 — *
MAYD Group GmbH ** ^Senior Secured13.8%2,480,536 2,271,204 1,168,473 *
Prima Holdings Limited ** ^Senior Secured13.0%2.0%2,012,562 1,959,296 1,959,296 1/1/2028
Surround Group, Inc.Senior Secured14.3%389,055 296,966 — *
Technology Services Total7.5%$21,911,937 $20,966,580 $16,081,838 
10


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Wireless
Juvo Mobile, Inc. **Senior Secured12.5%$4,530,848 $4,156,589 $4,156,589 6/1/2028
Nextivity, Inc.Senior Secured12.5%8.4%1,464,297 1,560,872 1,560,872 3/1/2028
Nextivity, Inc.Senior Secured12.5%8.4%5,098,783 5,254,844 5,254,844 12/1/2027
Nextivity, Inc.Senior Secured12.5%8.5%4,121,159 4,282,870 4,282,870 6/1/2028
Nextivity, Inc. Subtotal10,684,239 11,098,586 11,098,586 
Wireless Total7.1%$15,215,087 $15,255,175 $15,255,175 
Grand Total 150.9%$401,793,048 $361,596,615 $324,437,972 


Description and terms of payments to be received from another partyDescription and terms of payments to be paid to another partyCounterpartyMaturity DateNotional AmountFair ValueUpfront payments/receipts
Unrealized appreciation/ (depreciation)
(e)
Derivative Instruments - Interest Rate Collar Agreements
Floating interest rate of 1 mo. USD-SOFR CME Term with a cap rate of 5.3000% to be received monthly
Floating interest rate of 1 mo. USD-SOFR CME Term with a floor rate of 3.2400% to be paid monthly
Zions Bancorporation, N.A.12/31/2026$50,000,000 $(1,468)$— $(1,468)
Floating interest rate of 1 mo. USD-SOFR CME Term with a cap rate of 4.0000% to be received monthly
Floating interest rate of 1 mo. USD-SOFR CME Term with a floor rate of 2.9000% to be paid monthly
Zions Bancorporation, N.A.12/31/202750,000,000 132,744 — 132,744 
Total$100,000,000 $131,276 $— $131,276 

* As of June 30, 2026, loans with a cost basis of $94.1 million and a fair value of $60.3 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.

**Indicates assets that the Fund deems “non-qualifying assets.” As of June 30, 2026, 20.1% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund’s investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.

(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are generally the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Condensed Schedule of Investments based on a most advantageous market and the estimates may include the use of significant unobservable inputs.

(e) The unrealized appreciation/(depreciation) was valued using prices or valuation based on observable inputs other than quoted prices in active markets for identical assets and liabilities. See “Note 3. Fair Value Disclosures” for more information.

As of June 30, 2026, all loans were made to non-affiliates.



See notes to condensed financial statements (unaudited).





11



WTI FUND X, INC.

CONDENSED SCHEDULE OF INVESTMENTS (UNAUDITED)
AS OF DECEMBER 31, 2025

IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Biotechnology
Biolojic Design Ltd. ** ^Senior Secured12.5%3.0%$7,500,000 $7,102,545 $7,102,545 7/1/2028
Biolojic Design Ltd. ** ^Senior Secured12.5%4.0%1,490,871 1,643,257 1,643,257 8/1/2026
Biolojic Design Ltd. ** ^Senior Secured12.5%3.0%3,750,000 3,682,604 3,682,604 7/1/2028
Biolojic Design Ltd. ** ^ Subtotal12,740,871 12,428,406 12,428,406 
Mazen Animal Health Inc.Senior Secured14.3%3,104,711 3,019,495 2,260,705 *
Ukko Inc. ** ^Senior Secured11.5%656,145 650,198 650,198 5/1/2026
Biotechnology Total7.9%$16,501,727 $16,098,099 $15,339,309 
Computers & Storage
Canary Connect, Inc.Senior Secured12.0%$5,000,000 $5,134,605 $5,134,605 *
Proto, Inc.Senior Secured13.0%17.8%750,000 697,064 697,064 7/1/2028
Computers & Storage Total3.0%$5,750,000 $5,831,669 $5,831,669 
Internet
D2C Store, Inc.Senior Secured10.0%$856,869 $610,687 $610,687 1/1/2027
Findigs, Inc.Senior Secured13.5%2,352,030 2,274,782 2,274,782 7/1/2027
Giant Labs, Inc.Senior Secured12.8%1,827,417 1,978,792 1,978,792 3/1/2028
Miami Labs, Inc.Senior Secured13.3%675,288 651,684 651,684 2/1/2026
OneLocal, Inc. ** ^Senior Secured12.3%110,479 107,708 107,708 7/1/2026
Quantcast Corp.Senior Secured12.0%8,528,348 6,634,951 6,634,951 *
Realm Living, Inc.Senior Secured15.7%2,942,659 2,879,242 2,879,242 6/1/2027
RetailerX, Inc.Senior Secured11.0%7,345,775 6,888,793 6,888,793 *
Threedium, Inc. ** ^Senior Secured13.3%825,945 728,737 728,737 12/1/2027
Internet Total11.8%$25,464,810 $22,755,376 $22,755,376 
Medical Devices
Akadeum Life Sciences, Inc.Senior Secured14.3%$1,534,636 $1,372,741 $1,372,741 9/1/2027
eXo Imaging, Inc.Senior Secured12.5%3,750,000 3,219,508 3,219,508 12/1/2028
Gallant Pet, Inc.Senior Secured13.0%1,092,975 1,092,974 1,092,974 5/1/2028
Gallant Pet, Inc.Senior Secured13.3%1,821,790 1,682,539 1,682,539 5/1/2028
Gallant Pet, Inc.Senior Secured14.0%746,612 724,319 724,319 10/1/2026
Gallant Pet, Inc. Subtotal3,661,377 3,499,832 3,499,832 
Medical Devices Total4.2%$8,946,013 $8,092,081 $8,092,081 
Other Healthcare
CarePoint ** ^Senior Secured13.8%$838,466 $831,305 $428,377 *
Charlie Financial Inc.Senior Secured12.5%3.9%3,500,000 3,373,727 1,987,938 7/1/2028
Charlie Financial Inc.Senior Secured12.0%3.0%3,500,000 3,470,328 2,044,859 7/1/2028
Charlie Financial Inc. Subtotal7,000,000 6,844,055 4,032,797 
GoForward, Inc.Senior Secured12.8%20,352,673 18,206,436 9,077,441 *
KBS, Inc.Senior Secured14.0%57,314 56,181 56,181 6/1/2026
Lark Technologies, Inc.Senior Secured13.5%10,613,936 8,652,968 8,652,968 4/1/2028
Modern Animal, Inc.Senior Secured12.8%13,419,728 12,841,490 12,841,490 12/1/2030
Open Inc.Senior Secured14.8%58,770 58,646 58,646 3/1/2026
Open Inc.Senior Secured13.5%58,001 57,588 57,588 3/1/2026
Open Inc. Subtotal116,771 116,234 116,234 
12


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Vitable, Inc.Senior Secured13.0%4,500,000 4,257,659 4,257,659 4/1/2029
Yuva Biosciences, Inc.Senior Secured13.3%47,681 46,710 46,710 5/1/2026
Other Healthcare Total20.5%$56,946,569 $51,853,038 $39,509,857 
Other Technology
AI Tech Holdings, Inc.Senior Secured12.0%6.5%$536,351 $482,616 $482,616 10/1/2028
American Castanea PBCSenior Secured11.8%6.7%205,779 24,381 24,381 12/1/2027
American Castanea PBCSenior Secured11.8%6.7%575,000 584,070 584,070 10/1/2028
American Castanea PBC Subtotal780,779 608,451 608,451 
Azumo, Inc.Senior Secured12.8%957,356 913,213 453,370 *
Badiani Limited ** ^Senior Secured13.6%1,719,107 1,638,961 1,202,391 *
Belong, Inc.Senior Secured13.5%750,000 653,973 653,973 3/1/2029
Belong, Inc.Senior Secured13.5%1,500,000 1,056,618 1,056,618 3/1/2029
Belong, Inc. Subtotal2,250,000 1,710,591 1,710,591 
Bryte, Inc.Senior Secured10.0%1,694,943 1,708,963 1,003,561 *
Carbon Ridge, Inc.Senior Secured12.5%1,125,000 1,075,417 1,075,417 1/1/2029
Carbon Ridge, Inc.Senior Secured12.5%1,067,422 994,119 994,119 7/1/2028
Carbon Ridge, Inc. Subtotal2,192,422 2,069,536 2,069,536 
Cella Farms Inc.Senior Secured11.8%1,456,621 1,422,963 886,176 *
Coffee.ai Inc.Senior Secured11.0%1,101,447 936,235 936,235 8/1/2028
CornerUp, Inc.Senior Secured15.0%392,046 359,248 56,205 *
Creoate Limited ** ^Senior Secured12.8%1.0%418,910 415,840 415,840 12/1/2027
Creoate Limited ** ^Senior Secured12.8%487,500 482,946 482,946 10/1/2028
Creoate Limited ** ^Senior Secured12.8%462,636 458,825 458,825 7/1/2028
Creoate Limited ** ^Senior Secured15.5%257,682 255,570 255,570 2/1/2027
Creoate Limited ** ^Senior Secured12.8%1,125,000 1,040,873 1,040,873 5/1/2029
Creoate Limited ** ^Senior Secured12.8%1.0%446,231 444,090 444,090 10/1/2027
Creoate Limited ** ^Senior Secured14.0%29,154 29,086 29,086 3/1/2026
Creoate Limited ** ^Senior Secured12.8%1.0%542,453 539,282 539,282 11/1/2027
Creoate Limited ** ^Senior Secured12.8%1.0%382,750 379,587 379,587 1/1/2028
Creoate Limited ** ^Senior Secured12.8%157,863 156,568 156,568 8/1/2028
Creoate Limited ** ^Senior Secured12.8%404,801 375,483 375,483 4/1/2028
Creoate Limited ** ^Senior Secured12.8%581,176 576,490 576,490 5/1/2028
Creoate Limited ** ^Senior Secured12.8%449,920 446,347 446,347 6/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0%483,476 478,954 478,954 2/1/2028
Creoate Limited ** ^Senior Secured12.8%525,000 519,546 519,546 12/1/2028
Creoate Limited ** ^Senior Secured12.8%1.0%647,553 615,984 615,984 8/1/2027
Creoate Limited ** ^Senior Secured12.8%487,500 482,561 482,561 11/1/2028
Creoate Limited ** ^Senior Secured12.8%750,000 724,656 724,656 7/1/2029
Creoate Limited ** ^ Subtotal8,639,605 8,422,688 8,422,688 
Daisyco, Inc.Senior Secured10.8%3,750,000 3,446,333 3,446,333 4/1/2029
Eguana Technologies, Inc. ** ^Senior Secured12.0%3,107,383 2,762,835 1,714,182 *
Fanimal, Inc.Senior Secured11.8%547,646 479,476 — *
Fortull, Inc.Senior Secured11.0%375,000 312,811 312,811 1/1/2029
Gold Words, LLCSenior Secured12.0%529,581 516,887 516,887 12/1/2027
Heading Health Inc.Senior Secured12.5%1,208,548 941,507 260,896 *
High Definition Vehicle Insurance, Inc.Senior Secured14.5%9,217,489 8,962,198 8,962,198 4/1/2027
Higher Ground Education, Inc.Senior Secured15.0%20,918,631 14,646,680 18,536,918 *
Hint, Inc.Senior Secured13.8%4,962,197 3,638,353 3,638,353 1/1/2028
Holo, Inc.Senior Secured13.5%204,304 26,811 26,811 *
Innventure LLC **Senior Secured13.5%15,000,000 7,790,373 7,790,373 6/1/2028
Joy Memories, IncSenior Secured12.0%4,522,031 4,481,160 4,481,160 6/1/2027
Kindred Motorworks, Inc.Senior Secured12.0%6.4%7,500,000 7,333,230 7,333,230 7/1/2028
Last Energy Inc.Senior Secured13.8%4,246,369 3,947,839 3,947,839 4/1/2028
LendTable Inc.Senior Secured14.1%2,414,807 2,291,370 — *
13


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Logistech Solutions Pte. Ltd. ** ^Senior Secured12.1%398,954 351,769 351,769 3/1/2027
Mavenform, Inc.Senior Secured13.5%4,046,035 3,508,070 2,409,036 *
Merlin Labs, Inc.Senior Secured13.5%29,787,671 27,860,348 27,860,348 6/1/2027
NewGlobe Education, Inc. ** ^Senior Secured12.5%4.6%19,087,946 18,847,298 18,847,298 10/1/2027
Overdrive Products Inc.Senior Secured13.5%428,172 341,313 341,313 1/1/2028
Owlet Baby Care, Inc. ** Senior Secured12.0%7.8%5,259,169 4,651,074 4,651,074 1/1/2028
Plant Prefab, Inc.Senior Secured12.4%1,231,222 789,991 789,991 *
Ripple Foods, PBCSenior Secured12.0%8,422,058 8,286,535 8,286,535 6/1/2029
Rise Gardens, Inc.Senior Secured11.8%1,380,944 1,201,703 270,549 *
Romaine Empire, Inc.Senior Secured13.5%8,118,564 8,195,815 8,195,815 12/1/2027
Runzy, Inc.Senior Secured14.4%220,000 216,075 216,075 9/1/2028
Scripta Insights, Inc.Senior Secured12.5%2,121,189 2,029,603 2,029,603 4/1/2028
Sun Day Carwash, Inc.Senior Secured13.5%2.0%1,901,330 1,913,005 1,913,005 1/1/2027
Sun Day Carwash, Inc.Senior Secured13.5%2.0%950,665 972,589 972,589 1/1/2027
Sun Day Carwash, Inc. Subtotal2,851,995 2,885,594 2,885,594 
Supplant, Inc. ** ^Senior Secured13.7%1,801,277 1,691,973 922,530 *
TheSquareFoot, Inc.Senior Secured18.0%623,478 320,058 — *
TomoCredit, Inc.Senior Secured13.8%1,728,664 1,695,856 1,695,856 4/1/2027
Umbra Lab, Inc.Senior Secured15.3%2,261,449 2,234,617 2,234,617 10/1/2026
Umbra Lab, Inc.Senior Secured13.5%769,183 765,188 765,188 4/1/2026
Umbra Lab, Inc.Senior Secured13.5%6,422,575 6,220,716 6,220,716 1/1/2028
Umbra Lab, Inc. Subtotal9,453,207 9,220,521 9,220,521 
World Wrapps II, Inc.Senior Secured12.5%893,065 830,136 830,136 1/1/2029
Zeno Technologies, Inc.Senior Secured10.0%251,129 233,996 — *
Zimeno Inc.Senior Secured11.5%4,854,287 4,734,337 4,233,256 *
Other Technology Total89.5%$203,183,689 $179,743,393 $172,837,110 
Semiconductors & Equipment
Terradepth, Inc.Senior Secured12.5%$3,960,229 $3,831,814 $3,831,814 9/1/2028
Semiconductors & Equipment Total2.0%$3,960,229 $3,831,814 $3,831,814 
Software
Abacum Inc.Senior Secured12.8%$1,457,168 $1,433,077 $1,433,077 5/1/2028
Abacum Inc.Senior Secured13.5%557,799 546,844 546,844 10/1/2026
Abacum Inc. Subtotal2,014,967 1,979,921 1,979,921 
APIsecAI, Inc.Senior Secured12.0%1,500,000 1,405,172 1,405,172 5/1/2028
APIsecAI, Inc.Senior Secured12.0%750,000 722,718 722,718 1/1/2029
APIsecAI, Inc. Subtotal2,250,000 2,127,890 2,127,890 
Bito Inc.Senior Secured12.5%750,000 634,504 634,504 5/1/2029
Blackcart, Inc. ** ^Senior Secured13.3%842,703 826,153 — *
Bloomboard, Inc.Senior Secured12.0%4,303,351 4,249,241 4,249,241 3/1/2028
BlueCart, Inc.Senior Secured14.1%859,238 802,533 705,991 *
Bound Rates, Inc. ** ^Senior Secured13.0%1,238,214 1,189,414 1,189,414 12/1/2027
Common Sun, IncSenior Secured11.0%332,246 328,393 328,393 7/1/2026
Common Sun, IncSenior Secured11.0%200,038 200,037 200,037 1/1/2027
Common Sun, Inc Subtotal532,284 528,430 528,430 
Confirm HR, Inc.Senior Secured12.0%6.2%562,500 462,032 462,032 11/1/2028
Crowded Technologies, Inc.Senior Secured12.5%562,500 456,585 456,585 12/1/2028
Crowded Technologies, Inc.Senior Secured12.5%562,500 540,278 540,278 1/1/2029
Crowded Technologies, Inc. Subtotal1,125,000 996,863 996,863 
Eskalera, Inc.Senior Secured12.0%1,231,088 1,208,618 680,681 *
Family First, IncSenior Secured12.0%7.4%2,811,034 2,919,366 2,919,366 10/1/2027
14


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Form Remodel, Inc.Senior Secured11.0%585,436 581,935 — *
FutureProof Technologies, Inc.Senior Secured13.5%228,185 225,067 225,067 6/1/2026
Grokker, Inc.Senior Secured11.5%64,553 64,266 64,266 4/1/2026
Hoken Holdings Inc.Senior Secured13.0%399,384 376,199 — *
Ioogo Inc.Senior Secured13.5%4,830,303 4,616,297 — *
Ketch Kloud, Inc.Senior Secured13.0%3,968,835 3,894,232 3,894,232 4/1/2027
Kolors, Inc. ** ^Senior Secured13.3%2.5%1,525,028 1,538,826 1,538,826 2/1/2027
Kolors, Inc. ** ^Senior Secured13.5%2.5%1,280,553 1,294,817 1,294,817 6/1/2027
Kolors, Inc. ** ^ Subtotal2,805,581 2,833,643 2,833,643 
Kushki Group Holdings Ltd. ** ^Senior Secured13.0%7,028,034 6,694,819 6,694,819 8/1/2027
Manifold Inc.Senior Secured12.0%6.7%2,185,155 2,118,157 2,118,157 5/1/2028
Manifold Inc.Senior Secured12.0%6.5%750,000 707,326 707,326 7/1/2029
Manifold Inc. Subtotal2,935,155 2,825,483 2,825,483 
Merlyn Mind, Inc.Senior Secured13.1%25,666,873 20,721,570 20,721,570 1/1/2029
Migo Money, Inc. ** ^Senior Secured11.5%1,210,106 1,227,835 524,191 *
Parkoursc, Inc.Senior Secured12.8%1.0%1,023,604 1,030,773 1,030,773 10/1/2026
Parkoursc, Inc.Senior Secured13.0%764,684 724,367 724,367 10/1/2027
Parkoursc, Inc.Senior Secured13.0%914,019 895,912 895,912 3/1/2028
Parkoursc, Inc. Subtotal2,702,307 2,651,052 2,651,052 
Safe Securities Inc.Senior Secured12.3%1.0%1,963,449 1,961,986 1,961,986 10/1/2027
Safe Securities Inc.Senior Secured12.3%2,617,932 2,599,820 2,599,820 10/1/2027
Safe Securities Inc.Senior Secured11.5%1.0%4,125,000 3,630,867 3,630,867 5/1/2029
Safe Securities Inc.Senior Secured12.3%1.0%1,963,449 1,893,151 1,893,151 10/1/2027
Safe Securities Inc. Subtotal10,669,830 10,085,824 10,085,824 
Semsee Corp.Senior Secured14.3%1.0%1,433,470 1,414,281 1,414,281 1/1/2027
Standard Dental OpCo, Inc.Senior Secured10.0%20.1%9,000,000 8,134,425 8,134,425 10/1/2026
Standard Dental OpCo, Inc.Senior Secured10.0%21.0%2,250,000 2,290,726 2,290,726 10/1/2026
Standard Dental OpCo, Inc. Subtotal11,250,000 10,425,151 10,425,151 
Traction Apps, Inc. ** ^Senior Secured12.0%669,126 557,313 366,951 *
Truepic Inc.Senior Secured12.3%1,456,903 1,422,591 1,422,591 5/1/2028
Truepic Inc.Senior Secured12.3%618,047 527,618 527,618 12/1/2027
Truepic Inc. Subtotal2,074,950 1,950,209 1,950,209 
Vesta Housing, Inc.Senior Secured15.0%2.0%2,250,000 2,265,000 2,265,000 5/1/2026
Vesta Housing, Inc.Senior Secured11.8%264,526 263,286 263,286 6/1/2026
Vesta Housing, Inc.Senior Secured15.0%2.0%1,500,000 1,513,550 1,513,550 4/1/2026
Vesta Housing, Inc.Senior Secured11.8%264,526 260,999 260,999 6/1/2026
Vesta Housing, Inc.Senior Secured15.0%2.0%2,250,000 2,244,615 2,244,615 3/1/2026
Vesta Housing, Inc. Subtotal6,529,052 6,547,450 6,547,450 
ZeroCater, Inc.Senior Secured12.5%4,584,034 4,372,381 4,372,381 4/1/2028
Software Total47.7%$108,155,593 $99,989,972 $92,070,903 
Technology Services
Ava Finance, Inc.Senior Secured10.8%1.5%$375,000 $368,937 $368,937 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 734,762 734,762 2/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 612,248 612,248 9/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 733,676 733,676 11/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 735,463 735,463 1/1/2029
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 736,615 736,615 12/1/2028
Ava Finance, Inc.Senior Secured10.8%1.5%750,000 737,504 737,504 10/1/2028
Ava Finance, Inc. Subtotal4,875,000 4,659,205 4,659,205 
Klar Holdings Limited ** ^Senior Secured12.5%3,535,315 3,482,148 3,482,148 4/1/2028
Klar Holdings Limited ** ^Senior Secured12.5%3,642,590 3,585,948 3,585,948 5/1/2028
15


IndustryBorrowerPercent of Net Assets (a)CollateralInterest Rate
(b)
End of Term Payment
(c)
Principal
Amortized Cost
Fair Value
(d)
Final Maturity Date
Klar Holdings Limited ** ^Senior Secured12.5%3,425,652 3,135,233 3,135,233 3/1/2028
Klar Holdings Limited ** ^ Subtotal10,603,557 10,203,329 10,203,329 
Loansnap Holdings Inc. **Senior Secured10.3%3,669,060 3,485,045 — *
MAYD Group GmbH ** ^Senior Secured13.8%2,480,536 2,271,204 1,168,473 *
Prima Holdings Limited ** ^Senior Secured13.0%2.0%2,566,587 2,448,785 2,448,785 1/1/2028
Surround Group, Inc.Senior Secured14.3%389,055 296,966 — *
Techspert.IO Limited ** ^Senior Secured14.3%1,594,481 1,527,273 1,527,273 9/1/2027
Technology Services Total10.4%$26,178,276 $24,891,807 $20,007,065 
Wireless
Juvo Mobile, Inc. **Senior Secured12.5%$4,530,848 $4,388,123 $4,388,123 12/1/2027
Nextivity, Inc.Senior Secured12.5%8.4%1,827,015 1,896,255 1,896,255 3/1/2028
Nextivity, Inc.Senior Secured12.5%8.4%6,596,279 6,485,140 6,485,140 12/1/2027
Nextivity, Inc.Senior Secured12.5%8.5%5,000,000 5,068,598 5,068,598 6/1/2028
Nextivity, Inc. Subtotal13,423,294 13,449,993 13,449,993 
Wireless Total9.2%$17,954,142 $17,838,116 $17,838,116 
Grand Total 206.2%$473,041,048 $430,925,365 $398,113,300 

Description and terms of payments to be received from another partyDescription and terms of payments to be paid to another partyCounterpartyMaturity DateNotional AmountFair ValueUpfront payments/receiptsUnrealized depreciation
(e)
Derivative Instruments - Interest Rate Collar Agreements
Floating interest rate of 1 mo. USD-SOFR CME Term with a cap rate of 5.3000% to be received monthly
Floating interest rate of 1 mo. USD-SOFR CME Term with a floor rate of 2.3000% to be paid monthly
Zions Bancorporation, N.A.12/31/2025$50,000,000 $(49,831)$— $(49,831)
Floating interest rate of 1 mo. USD-SOFR CME Term with a cap rate of 5.3000% to be received monthly
Floating interest rate of 1 mo. USD-SOFR CME Term with a floor rate of 3.2400% to be paid monthly
Zions Bancorporation, N.A.12/31/2026$50,000,000 $(99,226)$— $(99,226)
Total$100,000,000 $(149,057)$— $(149,057)
* As of December 31, 2025, loans with a cost basis of $96.6 million and a fair value of $66.6 million were classified as non-accrual. These loans have been accelerated from their original maturity and are due in their entirety. During the period for which these loans have been on non-accrual status, no interest income has been recognized.

**Indicates assets that the Fund deems “non-qualifying assets.” As of December 31, 2025, 21.2% of the Fund’s total assets represented non-qualifying assets. Under Section 55(a) of the 1940 Act, the Fund is prohibited from acquiring any additional non-qualifying assets unless, at the time of acquisition, certain specified qualifying assets (e.g., securities issued by an “eligible portfolio company,” as defined in Section 2(a)(46)) represent at least 70% of its total assets. As part of this calculation, the numerator consists of the fair value of the Fund’s investments in all eligible portfolio companies, and the denominator consists of total assets less those assets described in Section 55(a)(7) of the 1940 Act.

^ Entity is not domiciled in the United States and does not have its principal place of business in the United States.

(a) The percentage of net assets that each industry group represents is shown with the industry totals (the sum of the percentages does not equal 100% because the percentages are based on net assets as opposed to total loans).

(b) The interest rate is the designated annual interest rate exclusive of any original issue discount, fees or end of term payment.

(c) The end of term payments are contractually due on the maturity date and are in addition to the interest rate shown. End of term payments are generally the percentage of the final payment divided by the original loan amount and are amortized over the full term of the loan.

(d) There is no readily available market price or secondary market for the Fund’s loan investments, hence the Manager determines fair value of all loan investments presented in the Condensed Schedule of Investments based on a most advantageous market and the estimates may include the use of significant unobservable inputs.

(e) The unrealized depreciation was valued using prices or valuation based on observable inputs other than quoted prices in active markets for identical assets and liabilities. See “Note 3. Fair Value Disclosures” for more information.


As of December 31, 2025, all loans were made to non-affiliates.


See notes to condensed financial statements (unaudited).
16




WTI FUND X, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)
1.ORGANIZATION AND OPERATIONS OF THE FUND

WTI Fund X, Inc. (the “Fund”) was incorporated in Maryland on October 19, 2020 as a non-diversified, closed-end management investment company that elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”) and is managed by Westech Investment Advisors LLC (the “Manager” or “Management”) whose ultimate parent is Ridgepost Capital, Inc. (formerly known as P10, Inc.), a Delaware corporation.

The Fund will be dissolved on December 31, 2031 unless the Board of Directors (the “Board”) opts to elect early dissolution. One hundred percent of the stock of the Fund is held by WTI Fund X, LLC (the “Company”). Prior to commencing investment operations on October 1, 2021, the Fund had no operations other than incurring organizational expenses and the sale to the Company of 100,000 shares of common stock at $0.001 par value (the “Shares”) in October 2020 and receipt of $25,000 from the Company as consideration for the purchase of the Shares. This issuance of stock was a requirement to apply for a finance lender’s license from the California Commissioner of Corporations, which was obtained on April 5, 2021.

The Fund’s investment objective is to achieve superior risk-adjusted investment returns and it seeks to achieve that objective by providing debt financing to portfolio companies, most of which are private. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets that are invested in different types of assets. The portfolio investments of the Fund primarily consist of debt financing to early and expansion stage venture capital-backed technology companies.


2. BASIS OF PRESENTATION

The accompanying condensed interim financial statements of the Fund have been prepared in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”) for interim financial reporting and pursuant to the requirements for reporting on Form 10-Q. Accordingly, they do not include all information and footnote disclosures required for audited annual financial statements. Certain disclosures have been omitted because they would substantially duplicate disclosures included in the Fund’s audited financial statements and related notes for the year ended December 31, 2025, which are included in the Fund’s Annual Report on Form 10-K (“Form 10-K”) filed with the United States Securities and Exchange Commission (“SEC”) on March 13, 2026. These condensed interim financial statements should be read in conjunction with the audited financial statements and notes included in the Fund’s annual report on Form 10-K as of and for the year ended December 31, 2025, including Note 2 - Summary of Significant Accounting Policies, which discusses the Fund’s significant accounting policies and estimates. In the opinion of the Manager, the accompanying condensed interim financial statements include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Fund’s financial position and results of operations for the interim periods presented. The results for the three and six months ended June 30, 2026 are not necessarily indicative of results for a full fiscal year.


3. FAIR VALUE DISCLOSURES

The Fund provides asset-based financing primarily to start-up and emerging growth venture-backed companies pursuant to commitments whereby the Fund agrees to finance assets and provide working or growth capital up to a specified amount for the term of the commitment, upon the terms and subject to the conditions specified by such commitment. Even though these loans are generally secured by the assets of the borrowers, the Fund in most cases is subject to the credit risk of such companies. As of June 30, 2026 and December 31, 2025, the Fund’s investments in loans were primarily to companies based within the United States and were diversified among borrowers in the industry segments shown in the Condensed Schedules of Investments. All loans are senior to unsecured creditors and other secured creditors, unless otherwise indicated in the Condensed Schedules of Investments.

The Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, a recovery price. The recovery price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. Because there is no readily available market price and no secondary market for substantially all of the loan investments made by the Fund to borrowing portfolio companies, Management determines fair value (or estimated recovery value) based on a transaction that would occur in the most advantageous market, and several factors related to each borrower.

Loan balances in the Condensed Schedules of Investments are listed by borrower. Typically, a borrower’s balance will be composed of several loans drawn under a commitment made by the Fund with the interest rate on each loan fixed at the time each loan is funded. Each loan drawn under a commitment has a different maturity date and amount.

17


The following tables show the weighted-average interest rate of the performing loans and all loans:

For the Three Months EndedFor the Six Months Ended
Performing LoansJune 30, 2026June 30, 2025June 30, 2026June 30, 2025
Weighted-Average Interest Rate - Cash19.70 %15.89 %22.28 %14.55 %
Weighted-Average Interest Rate - Non-Cash7.17 %5.06 %8.18 %4.30 %
Weighted-Average Interest Rate26.87 %20.95 %30.46 %18.85 %

For the Three Months EndedFor the Six Months Ended
All LoansJune 30, 2026June 30, 2025June 30, 2026June 30, 2025
Weighted-Average Interest Rate - Cash16.34 %13.79 %19.44 %12.80 %
Weighted-Average Interest Rate - Non-Cash5.94 %4.33 %6.80 %3.75 %
Weighted-Average Interest Rate22.28 %18.12 %26.24 %16.55 %

Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants and new loans funded during the period. Warrants and equity securities received in connection with loan transactions are measured at fair value at the time of acquisition; the non-cash portion of interest income represents the accretion of the discount of these warrants over the life of the loan.

The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and loan as discussed in the Fund’s loan accounting policy. Such changes result in the fair value adjustments made to the individual loans, which in accordance with U.S. GAAP, would be based on the price that would be received to sell an asset or paid to settle a liability in an orderly transaction between market participants at the measurement date. Where the risk profile is consistent with the original underwriting, the cost basis of substantially all of the loans approximates fair value.

All loans as of June 30, 2026 and December 31, 2025 were pledged as collateral for the debt facility, and the Fund’s borrowings are generally collateralized by all assets of the Fund.

Valuation Hierarchy

Under the FASB ASC Topic 820 (“Fair Value Measurement”), the Fund categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Fund’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety.

The three levels of the fair value hierarchy are defined as follows:

Level 1Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date.
Level 2Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities.
Level 3Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.

The Fund recognizes transfers between levels, if any, on the actual date of the event of change in circumstances that caused the transfer. There were no transfers in or out of Level 1, 2 or 3 during the three and six months ended June 30, 2026 and 2025.

For fair value disclosure purposes, the Fund has identified two classes of financial instruments: loan investments and derivative instruments. The Fund’s derivative instruments are based on quotes from the market makers that derive fair values from market data, and therefore, are classified as Level 2. The Fund’s loan investments are individually negotiated and unique, and because there is little to no market in which these assets trade, the unobservable inputs for these assets are valued using estimated recovery values. As a result, the Fund's loan investments are classified as Level 3.

The methodologies primarily employed by Management for valuation purposes consist of valuing loans based on the most advantageous market as discussed in Note 2 - Summary of Significant Accounting Policies of the Fund’s audited financial statements included in the Form 10-K, and the “asset recovery” method. The asset recovery method is utilized once Management identifies a troubled loan. This methodology incorporates various alternative outcomes based on all available information as of the valuation date. Each outcome is assigned a weighting depending on the facts and circumstances which exist at the underlying portfolio company. In certain scenarios, Management identifies all relevant remaining assets and the expected value of the proceeds the Fund may receive for selling off tangible assets or intellectual property rights, redeploying those assets to other companies, recovering receivables, etc. In other circumstances, Management considers the portfolio company’s potential ability to raise an additional round of financing or to be acquired which then allows for full or partial recovery of the Fund’s loan.

18


The following tables provide quantitative information about the Fund’s Level 3 fair value measurements of the Fund’s investments by industry as of June 30, 2026 and December 31, 2025. In addition to the techniques and inputs noted in the tables below, the Fund may also use other valuation techniques and methodologies when determining its fair value measurements.

Investment Type - Level 3
Loan Investments
Fair Value at June 30, 2026
Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average(a)
Biotechnology$13,603,123 Most advantageous market analysisMost advantageous market effective yield rate
16% - 17%
17%
Asset RecoveryProbability weighting of alternative outcomes
10% - 25%*^
Computers & Storage633,589 Most advantageous market analysisMost advantageous market effective yield rate
27% *
27%
Internet22,566,050 Most advantageous market analysisMost advantageous market effective yield rate
14% - 26%
17%
Asset RecoveryProbability weighting of alternative outcomes
15% - 65% ^
Medical Devices7,152,233 Most advantageous market analysisMost advantageous market effective yield rate
18% - 26%
21%
Other Healthcare28,398,521 Most advantageous market analysisMost advantageous market effective yield rate
15% - 17%
16%
Asset RecoveryProbability weighting of alternative outcomes
15% - 100% ^
Other Technology138,601,815 Most advantageous market analysisMost advantageous market effective yield rate
12% - 29%
16%
Asset RecoveryProbability weighting of alternative outcomes
10% - 100% ^
Semiconductors & Equipment5,692,748 Most advantageous market analysisMost advantageous market effective yield rate
14% - 21%
17%
Software76,452,880 Most advantageous market analysisMost advantageous market effective yield rate
11% - 27%
21%
Asset RecoveryProbability weighting of alternative outcomes
10% - 100%^
Technology Services16,081,838 Most advantageous market analysisMost advantageous market effective yield rate
14% - 19%
16%
Asset RecoveryProbability weighting of alternative outcomes
25% - 100% ^
Wireless15,255,175 Most advantageous market analysisMost advantageous market effective yield rate
18% - 22%
19%
Total Loan Investments$324,437,972 
(a) The weighted-average most advantageous market effective yield rates were calculated using the relative fair value of the loans.
^ Probability weightings vary among portfolio companies within this industry based on different potential future outcomes.
* There is only one loan within this industry that utilizes this valuation technique.

Investment Type - Level 3
Loan Investments
Fair Value at December 31, 2025
Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average(a)
Biotechnology15,339,309 Most advantageous market analysisMost advantageous market effective yield rate
15% - 17%
17%
Asset RecoveryProbability weighting of alternative outcomes
25% *
Computers & Storage5,831,669 Most advantageous market analysisMost advantageous market effective yield rate
27% *
27%
Asset RecoveryProbability weighting of alternative outcomes
30% - 40% *
Internet22,755,376 Most advantageous market analysisMost advantageous market effective yield rate
16% - 26%
19%
Asset RecoveryProbability weighting of alternative outcomes
10% - 65% ^
19


Investment Type - Level 3
Loan Investments
Fair Value at December 31, 2025
Valuation Techniques / MethodologiesUnobservable InputRange
Weighted Average(a)
Medical Devices8,092,081 Most advantageous market analysisMost advantageous market effective yield rate
18% - 26%
21%
Other Healthcare39,509,857 Most advantageous market analysisMost advantageous market effective yield rate
14% - 22%
15%
Asset RecoveryProbability weighting of alternative outcomes
5% - 50% ^
Other Technology172,837,110 Most advantageous market analysisMost advantageous market effective yield rate
14% - 29%
20%
Asset RecoveryProbability weighting of alternative outcomes
5% - 100% ^
Semiconductors & Equipment3,831,814 Most advantageous market analysisMost advantageous market effective yield rate
14% *
14%
Software92,070,903 Most advantageous market analysisMost advantageous market effective yield rate
13% - 27%
20%
Asset RecoveryProbability weighting of alternative outcomes
5% - 100% ^
Technology Services20,007,065 Most advantageous market analysisMost advantageous market effective yield rate
14% - 20%
16%
Asset RecoveryProbability weighting of alternative outcomes
25% - 100% ^
Wireless17,838,116 Most advantageous market analysisMost advantageous market effective yield rate
18%
18%
Total Loan Investments$398,113,300 

(a) The weighted-average most advantageous market effective yield rates were calculated using the relative fair value of the loans.
^ Probability weightings vary among portfolio companies within each industry based on different potential future outcomes.
* There is only one loan within this industry that utilizes this valuation technique.

Increases (or decreases) in the most advantageous market effective yield rate, in isolation, could result in a significantly lower (or higher) fair value measurement. Likewise, increases (or decreases) in the probability weighting of unfavorable outcomes could decrease (increase) the fair value of the loan investments significantly. These sensitivities vary across industry segments and individual borrowers.

The following tables present the balances of assets and liabilities as of June 30, 2026 and December 31, 2025 measured at fair value on a recurring basis:

As of June 30, 2026
ASSETS:Level 1Level 2Level 3Total
Loans †$— $— $324,437,972 $324,437,972 
Derivative assets— 132,744 — 132,744 
Total assets$— $132,744 $324,437,972 $324,570,716 
LIABILITIES:Level 1Level 2Level 3Total
      Derivative liabilities$— $1,468 $— $1,468 
Total liabilities$— $1,468 $— $1,468 

† For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedule of Investments.
20


As of December 31, 2025
ASSETS:Level 1Level 2Level 3Total
Loans †$— $— $398,113,300 $398,113,300 
Total assets$— $— $398,113,300 $398,113,300 
LIABILITIES:Level 1Level 2Level 3Total
Derivative liabilities$— $149,057 $— $149,057 
Total liabilities$— $149,057 $— $149,057 

† For a detailed listing of borrowers comprising this amount, please refer to the Condensed Schedule of Investments.

The following tables provide a summary of changes in Level 3 assets measured at fair value on a recurring basis:

For the Three Months Ended June 30, 2026
LoansWarrants
Beginning balance$334,975,067 $— 
Acquisitions and originations35,000,000 4,980,825 
Principal payments on loans, net of accretion(43,253,718)— 
Distributions to shareholder— (4,980,825)
Net realized loss from loans(205,616)— 
Net change in unrealized loss from loans(2,077,761)— 
Ending balance$324,437,972 $— 
Net change in unrealized loss from loans still held at June 30, 2026
$(2,077,761)

For the Six Months Ended June 30, 2026
LoansWarrants
Beginning balance$398,113,300 $— 
Acquisitions and originations65,350,000 8,506,127 
Principal payments on loans, net of accretion(133,270,782)— 
Distributions to shareholder— (8,506,127)
Net realized loss from loans(1,407,968)— 
Net change in unrealized loss from loans(4,346,578)— 
Ending balance$324,437,972 $— 
Net change in unrealized loss from loans still held at June 30, 2026
$(6,452,939)

For the Three Months Ended June 30, 2025
LoansWarrants
Convertible Notes
Beginning balance$452,389,465 $— $— 
Acquisitions and originations12,075,000 4,552,187 110,875 
Principal payments on loans, net of accretion(36,769,611)— — 
Distributions to shareholder— (4,552,187)(110,875)
Net realized loss from loans(101,895)— — 
Net change in unrealized loss from loans(1,659,759)— — 
Ending balance$425,933,200 $— $— 
Net change in unrealized loss from loans still held at June 30, 2025
$(1,787,473)

21


For the Six Months Ended June 30, 2025
LoansWarrantsConvertible Notes
Beginning balance$440,132,395 $— $— 
Acquisitions and originations60,487,000 10,616,688 910,751 
Principal payments on loans, net of accretion(65,253,860)— — 
Distributions to shareholder— (10,616,688)(910,751)
Net realized loss from loans(101,895)— — 
Net change in unrealized loss from loans(9,330,440)— — 
Ending balance$425,933,200 $— $— 
Net change in unrealized loss from loans still held at June 30, 2025
$(9,581,140)


4. EARNINGS PER SHARE

Basic earnings per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding. Diluted earnings (loss) per share are computed by dividing net increase (decrease) in net assets resulting from operations by the weighted average common shares outstanding, including the dilutive effects of potential common shares (e.g., stock options). The Fund has no instruments that would be potential common shares; thus, reported basic and diluted earnings (loss) per share are the same.


5. CAPITAL STOCK

As of both June 30, 2026 and December 31, 2025, there were 10,000,000 shares of $0.001 par value common stock authorized, and 100,000 shares issued and outstanding. Total committed capital of the Company, as of both June 30, 2026 and December 31, 2025, was $500.0 million. As of June 30, 2026 and December 31, 2025, total contributed capital to the Company was $427.0 million and $400.0 million, respectively, of which $384.0 million and $358.0 million was contributed to the Fund, respectively.

The chart below shows the distributions of the Fund for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Cash distributions$27,000,000 $31,700,000 
Distributions of securities8,506,127 11,527,439 
Total distributions to shareholder$35,506,127 $43,227,439 
Final classification of the distributions as either a return of capital or a distribution of income is an annual determination made at the end of each year dependent upon the Fund’s current year cumulative earnings and profits.


6. DEBT FACILITY

The 1940 Act requires a BDC to meet certain levels of asset coverage with respect to its outstanding “senior securities,” which typically consist of outstanding borrowings under credit facilities and other debt instruments. BDCs are generally required to have an asset coverage of at least 200% but are permitted to increase the amount of indebtedness they may incur by lowering the asset coverage requirement from 200% to 150% if they make certain disclosures and obtain the approval by either (1) a “required majority,” as defined in Section 57(o) of the 1940 Act, of the BDC’s board of directors, including a majority of disinterested directors, with effectiveness one year after the date of such approval or (2) a majority of votes cast at a special or annual meeting of the BDC’s shareholders at which a quorum is present, which is effective the day after such shareholder approval.

On April 30, 2021, the Fund’s sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. As of June 30, 2026 and December 31, 2025, the Fund’s asset coverage for borrowings was 267% and 183%, respectively.

The Fund is a party to a loan and security agreement (as amended and restated from time to time, the “Loan and Security Agreement”) with ING Capital LLC acting as the administrative agent and the other lenders named therein, that established a secured revolving credit facility with a commitment size of $250.0 million. An additional $125.0 million is potentially available to the Fund, subject to further negotiation and credit approval, through an accordion provision.


22


Borrowings of the Fund are collateralized by (i) the personal property and other assets of the Fund (“Portfolio Secured Borrowings”) and (ii) up to the sum of the unfunded capital commitments of the Company’s investors, the rights of the Manager to such capital commitments (“Subscription Secured Borrowings”). In the event of default, the Manager’s right to receive management fees from the Fund is subordinate to the liens of the lenders. The Subscription Secured Borrowings component of the facility expires on the commitment period expiration date. Upon expiration of the Fund’s commitment period on June 30, 2026, the Fund is no longer permitted to incur borrowings under the Subscription Secured Borrowings component. The facility terminates on October 18, 2026, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or mandatory principal payments, if any. The Fund is currently evaluating options to extend, renew or replace the existing facility. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, an Adjusted Term SOFR Loan or a Daily Compounded SOFR Loan (each as defined below).

The Fund pays interest on its borrowings and a fee on the unused portion of the facility. Borrowings under the facility, at the Fund’s discretion, will bear interest at an annual rate of either a (i) Reference Rate, plus an Applicable Reference Rate Margin (such loan, a “Reference Rate Loan”), (ii) Adjusted Term SOFR plus the Applicable SOFR Margin (such loan, an “Adjusted Term SOFR Loan”) or (iii) Daily Compounded SOFR plus the Applicable SOFR Margin (such loan, a “Daily Compounded SOFR Loan”). As of June 30, 2026, the Fund’s outstanding borrowings were entirely 1-month Adjusted Term SOFR Loans. The interest period for each Adjusted Term SOFR Loan shall at the option of the Fund be fixed at one, three or six months. Adjusted Term SOFR is a rate per annum equal to Term SOFR for the elected interest period plus a fixed SOFR Adjustment of 0.11448%, 0.26161% or 0.42826% for interest periods of one, three or six months, respectively. Applicable SOFR Margin is the sum of (a) the product of (i) the Subscription Secured Borrowings percentage calculated for such period and (ii) 1.75% and (b) the product of (i) the Portfolio Secured Borrowings percentage for such period and (ii) 2.50%. When the Fund is using 50.00% or more of the maximum amount available under the Loan Agreement, the applicable unused line fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable unused line fee is 0.50% of the unused portion. The Fund pays the unused credit line fee quarterly.

Bank fees and other costs of $2.2 million incurred in connection with the acquisition and amendment of the facility have been capitalized and are amortized to interest expense on a straight-line basis over the life of the facility, which is expected to terminate on October 18, 2026. As of June 30, 2026 and December 31, 2025, the remaining unamortized fees and costs are $0.1 million and $0.4 million, respectively.

The facility is revolving and as such does not have a specified repayment schedule, although advances are secured by the assets of the Fund and thus repayments will be required as assets decline. The facility contains various covenants including financial covenants related to: (i) minimum debt service coverage ratio, (ii) interest coverage ratio, (iii) unfunded commitment ratio, (iv) maximum quarterly loan loss reserve ratio, (v) maximum annual loan loss reserve ratio and (vi) maximum loan loss test. There are also various restrictive covenants, including limitations on: (i) the incurrence of liens, (ii) consolidations, mergers and asset sales and (iii) capital expenditures. The Fund is also required to maintain derivative instruments covering a notional principal amount of at least 20% of the aggregate principal balance of the outstanding borrowings (the “Minimum Hedge Percentage”). The Fund is required to comply with this Minimum Hedge Percentage only after the date on which the Subscription Secured Borrowings percentage is less than 25% of the Fund’s borrowing base (see Note 8). As of both June 30, 2026 and December 31, 2025, Management is not aware of instances of non-compliance with financial covenants.

The carrying value of the Fund’s borrowings under the debt facility approximates fair value. The fair value of the borrowings leverages rates that are observable at commonly quoted intervals, which is classified as a Level 2 fair value measurement in the fair value hierarchy. As of June 30, 2026 and December 31, 2025, $128.0 million and $232.5 million, respectively, was outstanding under the debt facility, with a weighted average all-in interest rate of 5.89% and 6.16%, respectively.


7. MANAGEMENT FEE AND RELATED PARTIES

Management Fee

As compensation for its services to the Fund, the Manager, from the date of the first capital contribution, October 1, 2021, receives an investment management fee from the Fund (the “Management Fee”). The aggregate annual amount of the Management Fee for each annual period (which is comprised of four whole fiscal quarters and which, in the case of the first year, commenced on the first day of the first fiscal quarter following the first capital contribution) calculated as a percentage of committed capital, is as follows:
Management Fee
Year 11.575%
Year 21.600%
Year 31.575%
Year 41.500%
Year 51.250%
Year 60.900%
Year 70.600%
Year 80.350%
Year 90.150%
23



There will be no Management Fee payable after the ninth-year anniversary of the first capital contribution date.

For the three and six months ended June 30, 2026 and 2025, Management Fees were calculated at 1.250% and 1.500% of the Company’s committed capital, respectively. Management Fees of $1.6 million and $1.9 million were recognized as expenses for the three months ended June 30, 2026 and 2025, respectively. Management Fees of $3.1 million and $3.8 million were recognized as expenses for the six months ended June 30, 2026 and 2025, respectively.

Related Parties

Certain officers and directors of the Fund also serve as officers and directors of the Manager. The Articles of Incorporation of the Fund provide for indemnification of directors, officers, employees and agents (including the Manager) of the Fund to the fullest extent permitted by applicable state law and the 1940 Act, including the advance of expenses and reasonable counsel fees. The Articles of Incorporation of the Fund also contain a provision eliminating personal liability of a Fund director or officer to the Fund or its shareholder for monetary damages for certain breaches of their duty of care. For this reason, the Fund has acquired a directors and officers insurance policy.

Transactions with WTI Fund XI, Inc. (“Fund XI”)
The Manager also serves as the investment manager for Fund XI. So long as Fund XI has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which the Fund’s term of existence automatically expires), the Fund may invest in each portfolio company in which Fund XI invests, subject to the approval of the Fund’s Board. The Manager’s allocation process is designed to allocate investment opportunities fairly and equitably among the Fund and Fund XI over time and subject to the respective funds’ board approval, may be based on a methodology taking into account investment pace, the remaining commitment periods and other relevant factors.

The ability of the Fund to co-invest with Fund XI and other clients advised by the Manager is subject to the conditions (the “Conditions”) with which the funds are currently complying while seeking certain exemptive relief from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. To the extent that clients, other than Fund XI, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.


8.    DERIVATIVE INSTRUMENTS

The Fund uses derivative instruments to manage its exposure to interest rates on expected borrowings under its debt facility (see Note 6), as the Fund originates fixed rate loans.

The Fund entered into interest rate collar transactions with Zions Bancorporation, N.A. dba California Bank & Trust. Certain information related to the Fund’s interest rate collar contracts is presented below:

CounterpartiesEffective DateNotional AmountCapFloorIndexMaturity Date
Zions Bancorporation, N.A.12/31/2024$50,000,0005.30%3.24%1 mo.USD-SOFR CME Term12/31/2026
Zions Bancorporation, N.A.12/31/2025$50,000,0004.00%2.90%1 mo.USD-SOFR CME Term12/31/2027

The interest rate collar mitigates the Fund’s exposure to interest rate fluctuations on variable rate index of the debt facility. The collar establishes a range where the Fund pays the counterparty if the SOFR rate falls below the established floor rate, and the counterparty will pay the Fund if the SOFR rate exceeds the established cap rate. The interest rate collar settles monthly.

The following table shows the Fund’s derivative instruments at fair value on the Fund’s Condensed Statements of Assets and Liabilities as of June 30, 2026 and December 31, 2025:
    
Derivative AssetsDerivative Liabilities
Derivative InstrumentsJune 30, 2026December 31, 2025June 30, 2026December 31, 2025
Interest rate collar$132,744 $— $1,468 $149,057 


24


The following table shows the effect of the Fund’s derivative instruments on the Fund’s Condensed Statements of Operations:

For the Three Months EndedFor the Six Months Ended
Derivative InstrumentsCondensed Statements of Operations CaptionJune 30, 2026June 30, 2025June 30, 2026June 30, 2025
Interest rate collarNet change in unrealized gain (loss) from derivative instruments$125,529 $(3,607)$280,333 $(103,780)

The following table shows the Fund’s assets and liabilities related to derivatives by counterparty, net of amounts available for offset under the master netting agreement and net of any collateral received or pledged by the Fund for such assets and liabilities as of June 30, 2026 and December 31, 2025:
As of June 30, 2026
CounterpartiesDerivative Asset Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash Collateral PledgedCash Collateral Pledged
Net Amount (1)
Zions Bancorporation, N.A.$132,744 $— $— $— $132,744 
Total$132,744 $— $— $— $132,744 
As of June 30, 2026
CounterpartiesDerivative Liability Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash Collateral PledgedCash Collateral Pledged
Net Amount (2)
Zions Bancorporation, N.A.$(1,468)$— $— $— $(1,468)
Total$(1,468)$— $— $— $(1,468)

As of December 31, 2025
CounterpartiesDerivative Liability Subject to Master Netting AgreementDerivatives Available for OffsetNon-cash Collateral PledgedCash Collateral Pledged
Net Amount (2)
Zions Bancorporation, N.A.$(149,057)$— $— $— $(149,057)
Total$(149,057)$— $— $— $(149,057)
(1) Net amount of derivative assets represents the net amount due from the counterparty to the Fund.
(2) Net amount of derivative liabilities represents the net amount owed by the Fund to the counterparty.
There were no derivative assets as of December 31, 2025.


9. COMMITMENTS AND CONTINGENCIES

Unexpired Unfunded Commitments

As of June 30, 2026 and December 31, 2025, the Fund’s unexpired unfunded commitments to borrowers totaled $85.8 million and $82.5 million, respectively. Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is the Manager’s experience that not all unexpired unfunded commitments will be used by the borrowers. Many credit agreements contain provisions which are milestone dependent and not all borrowers will achieve these milestones. Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a material adverse change to its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investments for the Fund.

The tables below are the Fund’s unexpired unfunded commitments as of June 30, 2026 and December 31, 2025:

BorrowerIndustry
Unexpired Unfunded Commitment as of June 30, 2026
Expiration Date
Abacum Inc.Software$15,000,000 03/31/27
Belong, Inc.Other Technology375,000 07/31/26
Cofertility, Inc.Other Technology1,250,000 02/15/27
Crowded Technologies, Inc.Software1,125,000 07/31/26
eXo Imaging, Inc.Medical Devices3,750,000 07/31/26
Fortull, Inc.Other Technology375,000 10/31/26
Global Publishing Interactive, Inc.Software750,000 02/28/27
GoForward, Inc.Other Healthcare30,000,000 12/31/26
25


BorrowerIndustry
Unexpired Unfunded Commitment as of June 30, 2026
Expiration Date
Jericho Security, Inc.Software250,000 10/31/26
Lucra Inc.Software3,000,000 07/31/27
Merlyn Mind, Inc.Software5,000,000 12/31/26
Orion Longevity, Inc.Other Technology3,500,000 09/30/26
Outbuild Technologies, Inc.Software1,000,000 07/31/26
Pioneers Educaton, Inc.Other Technology4,000,000 12/31/26
Safe Securities Inc.Software10,875,000 06/30/27
Slice Solutions, Inc.Internet2,500,000 12/15/26
Workspot, Inc.Software1,500,000 06/30/29
World View Enterprises Inc.Other Technology1,500,000 01/31/27
Total$85,750,000 

BorrowerIndustry
Unexpired Unfunded Commitment as of December 31, 2025
Expiration Date
Abacum Inc.Software$15,000,000 03/31/27
Ava Finance, Inc.Technology Services1,500,000 03/31/26
Bito Inc.Software375,000 03/31/26
Creoate LimitedOther Technology375,000 01/31/26
Crowded Technologies, Inc.Software1,125,000 07/31/26
Daisyco, Inc.Other Technology3,750,000 06/30/26
eXo Imaging, Inc.Medical Devices3,750,000 07/31/26
Fortull, Inc.Other Technology750,000 10/31/26
GoForward, Inc.Other Healthcare30,000,000 12/31/26
Lark Technologies, Inc.Other Healthcare7,500,000 04/30/26
Prima Holdings LimitedTechnology Services3,000,000 04/30/26
Safe Securities Inc.Software10,875,000 06/30/27
Teiko Bio, Inc.Biotechnology1,500,000 06/30/26
Vitable, Inc.Other Healthcare3,000,000 03/14/26
Total$82,500,000 


Contingencies

In the normal course of business, the Manager may enter into certain contracts, on behalf of the Fund, that contain a variety of indemnifications. The Fund’s maximum exposure under these arrangements is unknown as this would involve future claims that may be made that have not yet occurred. Currently, no such claims exist or are expected to arise and, accordingly, the Fund has not accrued any liability in connection with such indemnifications.


10. SEGMENT INFORMATION

The Fund operates through a single operating and reportable segment with an objective to invest and generate returns by providing debt financing to start-up and emerging growth venture-backed companies across various geographies, primarily in the U.S.; revenues are derived from interest income earned on the debt financing. The Fund’s chief operating decision maker (“CODM”) is comprised of the officers of the Fund (inclusive of the Chief Executive Officer and Chief Financial Officer, among others) and evaluates segment performance and makes operating decisions of the Fund based on the net increase (or decrease) in net assets from operations (“net income”). In addition to numerous other factors and metrics, the CODM utilizes net income as a key metric in deciding whether to reinvest in the segment (i.e., loan fundings), call capital, pay dividends or service its debt. As the Fund’s operations comprise a single reportable segment, the segment assets are reflected on the accompanying Condensed Statements of Assets and Liabilities as “Total assets” and the significant segment expenses are listed on the accompanying Condensed Statements of Operations.



26


11. FINANCIAL HIGHLIGHTS

U.S. GAAP requires disclosure of financial highlights of the Fund for the three and six months ended June 30, 2026 and 2025.
    
The total rate of return is defined as the return based on the change in value during the period of a theoretical investment made at the beginning of the period. The total rate of return assumes a constant rate of return for the Fund during the period reported and weights each cash flow by the amount of time held in the Fund. This required methodology differs from an internal rate of return.

The ratios of expenses and net investment income to average net assets, calculated in the following table, are computed based upon the aggregate weighted average net assets of the Fund for the periods presented. Net investment income is inclusive of all investment income net of expenses and excludes realized or unrealized gains and losses.

Beginning and ending net asset values per share are based on the beginning and ending number of shares outstanding. Other per share information is calculated based upon the aggregate weighted average net assets of the Fund for the periods presented.

The following per share data and ratios have been derived from the information provided in the financial statements:

For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Total return**6.19 %5.48 %17.02 %6.76 %
Per share amounts:
Net asset value, beginning of period$1,896.62 $2,417.47 $1,930.32 $2,303.45 
Net investment income 139.23 149.98 368.95 257.34 
Net realized and change in unrealized loss from loans and derivative instruments(21.57)(17.66)(54.74)(95.36)
Net increase in net assets resulting from operations117.66 132.32 314.21 161.98 
Distributions of income to shareholder(124.81)(148.96)(342.50)(256.32)
    Return of capital to shareholder— (147.67)(12.56)(175.95)
Contributions from shareholder260.00 — 260.00 220.00 
Net asset value, end of period$2,149.47 $2,253.16 $2,149.47 $2,253.16 
Net assets, end of period$214,947,177 $225,316,126 $214,947,177 $225,316,126 
Ratios to average net assets:
Expenses*9.27 %9.98 %9.82 %10.09 %
Net investment income*29.26 %24.83 %38.50 %21.10 %
Portfolio turnover rate — %— %— %— %
           Average debt outstanding$159,875,000 $219,750,000 $187,428,571 $227,214,286 

*Annualized
**Total return amounts presented above are not annualized


12. SUBSEQUENT EVENTS

Management evaluated subsequent events through the date of this Quarterly Report on Form 10-Q and determined that no subsequent events had occurred that would require accrual or disclosure in the financial statements.



27


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

In addition to the historical information contained herein, the information in this Quarterly Report on Form 10-Q contains certain “forward-looking statements” within the meaning of the securities laws. These forward-looking statements reflect the current view of the Fund with respect to future events and financial performance and are subject to several risks and uncertainties, many of which are beyond the Fund’s control. All statements, other than statements of historical facts included in this Quarterly Report, regarding the strategy, future operations, financial position, estimated revenues, projected costs, prospects, plans and objectives of the Fund are forward-looking statements. When used in this report, the words “will,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. All forward-looking statements speak only as of the date of this report. The Fund does not undertake any obligation to update or revise publicly any forward-looking statements, whether resulting from new information, future events or otherwise, except as required by law.

The reader of this Quarterly Report should understand that all such forward-looking statements are subject to various uncertainties and risks that could affect their outcome. The Fund’s actual results could differ materially from those suggested by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, variances in the actual versus projected growth in assets, return on assets, loan losses, expenses, rates charged on loans and earned on securities investments, competition and macro-economic changes including inflation, interest rate expectations, among other factors including those set forth in the section of this Quarterly Report titled “Risk Factors” and in Item 1A - “Risk Factors” in the Fund’s 2025 Annual Report on Form 10-K. This entire Quarterly Report should be read to put such forward-looking statements in context and to gain a more complete understanding of the uncertainties and risks involved in the Fund’s business.


Overview

The Fund is 100% owned by the Company. The Fund’s shares of common stock, at $0.001 par value, were sold to its sole shareholder, the Company, under a stock purchase agreement. The Fund has issued 100,000 of the Fund’s 10,000,000 authorized shares. The Company may make additional capital contributions to the Fund.

The Fund provides financing and advisory services to a variety of carefully selected venture-backed companies that have received equity funding from traditional sources of venture capital equity funding (i.e., a professionally managed venture capital firm), as well as non-traditional sources of venture capital equity funding (e.g., angel investors, strategic investors, family offices, crowdfunding investment platforms, etc.) (collectively, “Venture-Backed Companies”), primarily throughout the United States with a focus on growth-oriented companies. The Fund’s portfolio consists of companies in the communications, information services, media, technology (including software and technology-enabled business services), biotechnology, and medical devices industry sectors, among others. The Fund’s capital is generally used by its portfolio companies to finance acquisitions of fixed assets and working capital. On October 1, 2021, the Company completed its first closing of capital contributions. On the same day, the Fund made its first investment and became a non-diversified, closed-end investment company that elected to be treated as a BDC under the 1940 Act. While the Fund intends to operate as a non-diversified investment company within the meaning of Section 5(b)(2) of the 1940 Act, from time to time, the Fund may instead act as a diversified investment company within the meaning of Section 5(b)(1) of the 1940 Act.

The Fund elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986 (the “Code”) for federal income tax purposes. Pursuant to this election, the Fund generally will not have to pay corporate-level taxes on any income distributed to its shareholder as dividends, allowing the Company to substantially reduce or eliminate its corporate-level tax liability.

The Fund will seek to meet the ongoing requirements, including the diversification requirements, to qualify as a RIC under the Code. If the Fund fails to meet these requirements, it will be taxed as an ordinary corporation on its taxable income for that year (even if that income is distributed to the members of the Company as ordinary income); thus, such income will be subject to a double layer of taxation. There is no assurance that the Fund will meet the ongoing requirements to qualify as a RIC for tax purposes.

The Fund’s investment objective is to achieve superior risk-adjusted investment returns. The Fund seeks to achieve that objective by providing debt financing to portfolio companies, most of which are private debt securities. The Fund generally receives warrants to acquire equity securities in connection with its portfolio investments and generally distributes these warrants to its shareholder upon receipt, or soon thereafter. The Fund also has guidelines for the percentages of total assets that are invested in different types of assets. The portfolio investments of the Fund primarily consist of debt financing to Venture-Backed Companies in the technology sector. The borrower’s ability to repay its loans may be adversely impacted by several factors, and as a result, the loan may not be fully repaid. Furthermore, the Fund’s security interest in any collateral over the borrower’s assets may be insufficient to make up any shortfall in payments. Some of the Fund’s portfolio companies may be impacted by rising inflation, which could have a material impact on their results of operations, specifically costs and revenues. As such, rising inflation may have an adverse impact on the portfolio borrowers’ ability to maintain their good credit standing, as well as their ability to pay their interest and principal obligations to the Fund. In addition, any projected future decreases in the Fund’s portfolio companies’ operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of the Fund’s investments could result in future unrealized losses and therefore reduce the Fund’s net assets resulting from operations.


28


The Fund’s investment income is also expected to decline following the end of the Fund’s commitment period which was extended by two calendar quarters through June 30, 2026. As the commitment period has now ended as of June 30, 2026, the Fund may no longer make loan commitments to reinvest the proceeds of matured investments in new loans. Any proceeds will be distributed to the Company.

The Fund operates through a single operating and reportable segment for financial reporting purposes, consistent with how the officers of the Fund (inclusive of the Chief Executive Officer and Chief Financial Officer, among others), who are the Fund’s CODM, evaluate financial performance and allocate resources.

Transactions with Fund XI
The Manager also serves as the investment manager for Fund XI. So long as Fund XI has capital available to invest in loan transactions with final maturities earlier than December 31, 2031 (the date on which the Fund’s term of existence automatically expires), the Fund may invest in each portfolio company in which Fund XI invests, subject to the approval of the Fund’s Board. The Manager’s allocation process is designed to allocate investment opportunities fairly and equitably among the Fund and Fund XI over time, and subject to board approval, may be based on a methodology taking into account investment pace, the remaining commitment periods and other relevant factors.

The ability of the Fund to co-invest with Fund XI and other clients advised by the Manager is subject to the Conditions with which the funds are currently complying while seeking certain exemptive relief from the SEC from the provisions of Sections 17(d) and 57 of the 1940 Act and Rule 17d-1 thereunder. To the extent that clients, other than Fund XI, advised by the Manager (but in which the Manager has no proprietary interest) invest in opportunities available to the Fund, the Manager will allocate such opportunities among the Fund and such other clients in a manner deemed fair and equitable considering all of the circumstances in accordance with the Conditions.
Critical Accounting Policies, Practices and Estimates
Critical Accounting Policies and Practices are those accounting policies and practices that are both the most important to the portrayal of the Fund’s net assets and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Critical accounting estimates are accounting estimates where the nature of the estimates is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and the impact of the estimates on net assets or operating performance is material.

In evaluating the most critical accounting policies and estimates, the Manager has identified the estimation of fair value of the Fund’s loan investments along with the completeness of loans exhibiting indicators of potential credit deterioration as the most critical of the accounting policies and accounting estimates applied to the Fund’s reporting of net assets or operating performance. In accordance with U.S. GAAP, the Fund defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability was exchanged in an orderly transaction; it was not a forced liquidation or distressed sale. There is no readily available market price or secondary market for the loans made by the Fund to borrowers, hence the Manager determines fair value based on a transaction that would occur in the most advantageous market and the estimates are subject to high levels of judgment and uncertainty. The Fund’s loan investments are considered Level 3 fair value measurements in the fair value hierarchy due to the lack of observability over many of the important inputs used in determining fair value. In particular, the Manager has identified the fair value of the Fund’s loan investments that exhibit indicators of the potential for credit deterioration and the completeness of those loan investments, as a critical accounting matter that may involve significant and material estimates and inputs from the Manager in determining the fair value of those loan investments.

Critical judgments and inputs in determining the fair value of a loan include the estimated timing and amount of future cash flows and probability of future payments, based on the assessment of payment history, available cash and “burn rate,” revenues, net income or loss, operating results, financial strength of borrower, prospects for the borrower’s raising future equity rounds, likelihood of sale or acquisition of the borrower, length of expected holding period of the loan, collateral position, the timing and amount of liquidation of collateral for loans that are experiencing significant credit deterioration and, as a result, collection becomes collateral-dependent, as well as an evaluation of the general interest rate environment. Management has evaluated these factors and has concluded that the effect of a deterioration in the quality of the underlying collateral, increase in the size of the loan, increase in the estimated time to recovery, and increase in the effective yield rate would each have the effect of decreasing the fair value of loan investments. The risk profile of a loan changes when events occur that impact the credit analysis of the borrower and the loan. Such changes result in the fair value being adjusted from par value of the individual loan. Where the risk profile is consistent with the original underwriting, the cost basis of substantially all loans approximates fair value.

The actual value of the loans may differ from Management’s estimates, which would affect net change in net assets resulting from operations as well as assets.


29


The Impact of Macro-level Conditions on Results of Operations and Liquidity & Capital Resources

Global and domestic financial markets remain volatile due to persistent inflationary pressures, interest rate fluctuations, and concerns about slowing economic growth. Geopolitical tensions, including the ongoing Ukraine War, war in the Middle East, in particular, involving the United States, Israel, Iran and the Gulf States, and continued instability in global shipping lanes have disrupted trade routes and supply chains. Recent escalations in the South China Sea and renewed cyberattacks targeting critical infrastructure have added to global uncertainty. Additionally, evolving U.S. government policies, global tariff regimes, and extreme weather events underscore the continuing political risk and risk of natural disasters and climate-related disruptions. These factors have created interruptions in supply chains and economic activity and have had a particularly adverse impact on certain industries. These uncertainties can ultimately impact the overall supply and demand of the market through changing spreads, deal terms and structures. The Fund is unable to predict the full impact of these macro risks on the Fund’s financial condition, including its liquidity and capital resources.

The Fund is continuing to maintain close communications with its loan portfolio companies to proactively assess and manage potential risks. In addition, Management is continuing to maintain oversight analysis of credits across the Fund’s loan investment portfolio in an attempt to manage the potential credit risk and improve loan performance. Certain loans may have inherent increased credit risk due to the nature of the underlying business and its ability to maintain operations in the current economic environment.

Management is also monitoring the Fund’s continued access to capital resources through periodic and timely communication with the bank syndicate and the Company’s members. In addition, the Fund will take proactive steps to ensure and maintain an appropriate liquidity position based on its circumstances. The Fund believes its existing cash balance, scheduled monthly payments from borrowers, and access to capital from its debt facility and the Company’s members will be sufficient to satisfy its working capital needs, debt repayments, and other liquidity requirements associated with its existing operations.
Results of Operations - For the Three and Six Months Ended June 30, 2026 and 2025

Analysis of Interest Income

Total investment income for the three months ended June 30, 2026 and 2025 was $18.3 million and $21.0 million, respectively. Total investment income for the six months ended June 30, 2026 and 2025 was $46.3 million and $38.0 million, respectively. Investment income primarily consisted of interest on venture loans outstanding and early loan payoffs. The remaining income consisted of interest and dividends on the temporary investment of cash.

Interest is calculated using the effective interest method, and rates earned by the Fund will fluctuate based on many factors including early payoffs, volatility of values ascribed to warrants, and new loans funded during the year. Warrants and equity securities received in connection with loan transactions are considered to be free standing contracts that are both legally detachable and separately exercisable from the related loan transactions and are measured at fair value at the time of acquisition; the non-cash portion of interest income represents the accretion of the discount of these warrants over the life of the loan.

The following table shows the average outstanding balance, interest income, and weighted average interest rate for the cash and non-cash portion of interest income for the three months ended June 30, 2026 and 2025:

For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025
Average Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash PortionAverage Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash Portion
Performing Loans$271,902,215 $18,266,838 19.70 %7.17 %$377,544,380 $19,777,353 15.89 %5.06 %
All Loans$327,936,253 $18,266,838 16.34 %5.94 %$441,342,063 $19,991,231 13.79 %4.33 %

Interest income for performing loans and all loans decreased by $1.5 million and $1.7 million, or 7.6% and 8.6%, respectively, for the three months ended June 30, 2026 compared to the same period in 2025. This is primarily attributable to a decline in the loan investment portfolio, which resulted in lower income, partially offset by higher income attributable to an increased number of early loan payoffs during the three months ended June 30, 2026 compared to the same period in 2025. The average outstanding balance for performing loans decreased by $105.6 million or 28.0%, for the three months ended June 30, 2026 compared to the same period in 2025. The average outstanding balance for all loans decreased by $113.4 million or 25.7%, for the three months ended June 30, 2026 compared to the same period in 2025.


30


The following table shows the average outstanding balance, interest income, and weighted average interest rate for the cash and non-cash portion of interest income for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Average Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash PortionAverage Outstanding BalanceInterest IncomeWeighted Average Interest Rate - Cash PortionWeighted Average Interest Rate - Non-Cash Portion
Performing Loans$292,620,283 $44,571,409 22.28 %8.18 %$387,812,526 $36,542,429 14.55 %4.30 %
All Loans$352,212,041 $46,203,918 19.44 %6.80 %$444,313,278 $36,772,075 12.80 %3.75 %
Interest income for both performing loans and all loans increased by $8.0 million and $9.4 million, or 22.0% and 25.6%, respectively, for the six months ended June 30, 2026 compared to the same period in 2025. The increase is primarily due to an increased number of early loan payoffs partially offset by lower interest income resulting from an increase in maturing loans, wherein the amortization schedule shifts to a greater proportion of each payment now being applied to the principal balance rather than interest during the six months ended June 30, 2026 in comparison to the same period in 2025. The average outstanding balance for performing loans and all loans decreased by $95.2 million and $92.1 million, or 24.5% and 20.7%, respectively, for the six months ended June 30, 2026 compared to the same period in 2025.


Analysis of Interest Expense

Interest expense was comprised of amounts related to interest on debt amounts drawn down, unused credit line fees, and amounts amortized from deferred fees incurred in conjunction with the debt facility.

The following table shows the average balance, interest expense, and weighted average interest expense rate for the three months ended June 30, 2026 and 2025.

For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025
Average BalanceInterest ExpenseWeighted Average Interest Expense RateAverage BalanceInterest ExpenseWeighted Average Interest Expense Rate
Debt Facility$159,875,000 $2,666,695 6.67 %$219,750,000 $3,862,968 7.03 %

Interest expense decreased by $1.2 million, or 31.0%, for the three months ended June 30, 2026 compared to the same period in 2025. Interest expense for the three months ended June 30, 2026, decreased primarily due to lower average debt outstanding and also lower weighted average interest rates. The average outstanding balance for borrowings under the facility decreased by $59.9 million, or 27.2%, for the three months ended June 30, 2026 compared to the same period in 2025.

The following table shows the average balance, interest expense, and weighted average interest rate for the six months ended June 30, 2026 and 2025.

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Average BalanceInterest ExpenseWeighted Average Interest Expense RateAverage BalanceInterest ExpenseWeighted Average Interest Expense Rate
Debt Facility$187,428,571 $5,926,122 6.32 %$227,214,286 $7,902,775 6.96 %

Interest expense decreased by $2.0 million, or 25.0%, for the six months ended June 30, 2026 compared to the same period in 2025. Interest expense for the six months ended June 30, 2026, decreased due to lower average debt outstanding and also lower weighted average interest rates. The average outstanding balance for borrowings under the facility decreased by $39.8 million, or 17.5%, for the six months ended June 30, 2026 compared to the same period in 2025.

The Fund also uses derivative instruments to manage its exposure to interest rates on its borrowings under the debt facility. See the discussion herein under the caption “Quantitative and Qualitative Disclosures About Market Risk” for the approximate annualized effect of hypothetical interest rate changes in components of net assets resulting from operations.



31


Analysis of Operating Expenses

The following table shows the components of operating expenses for the three and six months ended June 30, 2026 and 2025.

For the Three Months Ended June 30,For the Six Months Ended June 30,
Operating Expense20262025Change ($)20262025Change ($)
Management Fees$1,562,500 $1,875,000 $(312,500)$3,125,000 $3,750,000 $(625,000)
Banking and professional fees139,735 210,237 (70,502)211,888 530,322 (318,434)
Other operating expenses41,841 79,994 (38,153)147,646 120,326 27,320 
Total Operating Expenses$1,744,076 $2,165,231 $(421,155)$3,484,534 $4,400,648 $(916,114)

For the three and six months ended June 30, 2026 and 2025, Management Fees were calculated at 1.250% and 1.500% of the Company’s committed capital, respectively.

Banking and professional fees decreased by less than $0.1 million and $0.3 million, or 33.5% and 60.0%, respectively, for the three and six months ended June 30, 2026 compared to the same period in 2025. These expenses included legal fees, tax preparation fees and other consulting and professional service fees.

Other operating expenses decreased by less than $0.1 million, or 47.7% for the three months ended June 30, 2026 compared to the same period in 2025. Other operating expenses increased by less than $0.1 million, or 22.7% for the six months ended June 30, 2026 compared to the same period in 2025. Other operating expense included director fees, custody fees, taxes, insurance and other expenses related to the operations of the Fund.

Non-recurring fees

The Fund may receive non-recurring fees in connection with the origination and servicing of portfolio loans. Transactions in this category may include forfeited commitment fees and unamortized warrants that become recognized as other income after the loan commitment period expires. Other non-recurring fees include pre-payment fees which are recognized as other income in the period received. Legal fee reimbursements for deal due diligence and drafting of documents are recognized as offsets against legal expenses. Non-recurring fees for the three months ended June 30, 2026 and 2025 were $0.2 million and $0.9 million, respectively. Non-recurring fees for the six months ended June 30, 2026 and 2025 were $0.5 million and $1.2 million, respectively.

Net Investment Income

Net investment income for the three months ended June 30, 2026 and 2025 was $13.9 million and $15.0 million, respectively. Net
investment income for the six months ended June 30, 2026 and 2025 was $36.9 million and $25.7 million, respectively.

Realized and Change in Unrealized Gains (Losses)

Net realized losses from loans was $0.2 million and $0.1 million, for the three months ended June 30, 2026 and 2025, respectively. Net realized losses from loans was $1.4 million and $0.1 million, for the six months ended June 30, 2026 and 2025, respectively. Realized losses consisted of loans that were written off.

Net change in unrealized loss from loans was $2.1 million and $1.7 million for the three months ended June 30, 2026 and 2025, respectively. Net change in unrealized loss from loans was $4.3 million and $9.3 million for the six months ended June 30, 2026 and 2025, respectively. The net change in unrealized loss from loans consisted of fair value adjustments to the loans resulting from the improvement or deterioration in certain portfolio companies’ performance.

Net change in unrealized gain (loss) from derivative instruments was $0.1 million and less than $(0.1) million for the three months ended June 30, 2026 and 2025, respectively. Net change in unrealized gain (loss) from derivative instruments was $0.3 million and $(0.1) million for the six months ended June 30, 2026 and 2025, respectively. The net change in unrealized gain (loss) from derivative instruments consisted of fair market value adjustments to the derivative instruments and is a reflection of the market’s outlook on the economy and the future of interest rate changes, as well as realization of prior unrealized gains and losses.

Net increase in net assets resulting from operations for the three months ended June 30, 2026 and 2025 was $11.8 million and $13.2 million, respectively. On a per share basis, the net increase in net assets resulting from operations for the three months ended June 30, 2026 and 2025 was $117.66 and $132.32, respectively.

Net increase in net assets resulting from operations for the six months ended June 30, 2026 and 2025 was $31.4 million and $16.2 million, respectively. On a per share basis, the net increase in net assets resulting from operations for the six months ended June 30, 2026 and 2025 was $314.21 and $161.98, respectively.


32


Liquidity and Capital Resources – June 30, 2026 and December 31, 2025

The Fund is owned entirely by the Company. The Company is expected, but not required, to make further contributions to the capital of the Fund to the extent of the Company’s members’ capital commitment to the Company and excess cash balances of the Company. Total capital contributed to the Fund was $384.0 million and $358.0 million as of June 30, 2026 and December 31, 2025, respectively. As of both June 30, 2026 and December 31, 2025, the Company had subscriptions for capital in the amount of $500.0 million, of which $427.0 million and $400.0 million, respectively, had been called and received. The Manager exercised, and the Board of Directors ratified, its discretion to extend the Fund’s investment period for two additional quarters after December 31, 2025, thereby allowing the Fund to make new commitments through June 30, 2026 and to fund commitments through June 30, 2027, the end of the Fund’s investment period. As of June 30, 2026, $73.0 million of capital remains uncalled. The Company has made $150.8 million in recallable distributions to its investors, as permitted under its operating agreement between the Company’s managing member and members of the Company.

The changes in cash for the six months ended June 30, 2026 and 2025 were as follows:

For the Six Months Ended June 30, 2026 For the Six Months Ended June 30, 2025
Net cash provided by operating activities$97,454,583 $19,715,678 
Net cash used in financing activities(105,500,000)(34,700,000)
Net decrease in cash and cash equivalents$(8,045,417)$(14,984,322)

As of June 30, 2026 and December 31, 2025, 7.53% and 12.55%, respectively, of the Fund’s net assets consisted of cash.

The Fund is a party to the Loan and Security Agreement (as amended and restated from time to time) with ING Capital LLC acting as the administrative agent and the other lenders named therein, that established a secured revolving credit facility with a commitment size of $250.0 million. An additional $125.0 million is potentially available to the Fund, subject to further negotiation and credit approval, through an accordion provision.

Borrowings of the Fund are collateralized by (i) the personal property and other assets of the Fund (“Portfolio Secured Borrowings”) and (ii) up to the sum of the unfunded capital commitments of the Company’s investors, the rights of the Manager to such capital commitments (“Subscription Secured Borrowings”). In the event of default, the Manager’s right to receive management fees from the Fund is subordinate to the liens of the lenders. The Subscription Secured Borrowings component of the facility expires on the commitment period expiration date. Upon expiration of the Fund’s commitment period on June 30, 2026, the Fund is no longer permitted to incur borrowings under the Subscription Secured Borrowings component. The facility terminates on October 18, 2026, but can be accelerated in the event of default, such as the failure by the Fund to make timely interest or mandatory principal payments, if any. The Fund is currently evaluating options to extend, renew or replace the existing facility. Loans under the facility may be, at the option of the Fund, a Reference Rate Loan, an Adjusted Term SOFR Loan or a Daily Compounded SOFR Loan (each as defined below). The Fund pays interest on its borrowings and a fee on the unused portion of the facility. Borrowings under the facility, at the Fund’s discretion, will bear interest at an annual rate of either a (i) Reference Rate, plus an Applicable Reference Rate Margin (such loan, a “Reference Rate Loan”), (ii) Adjusted Term SOFR plus the Applicable SOFR Margin (such loan, an “Adjusted Term SOFR Loan”) or (iii) Daily Compounded SOFR plus the Applicable SOFR Margin (such loan, a “Daily Compounded SOFR Loan”). As of June 30, 2026, the Fund’s outstanding borrowings were entirely Adjusted Term SOFR Loans. The interest period for each Adjusted Term SOFR Loan shall at the option of the Fund be fixed at one, three or six months. Adjusted Term SOFR is a rate per annum equal to Term SOFR for the elected interest period plus a fixed SOFR Adjustment of 0.11448%, 0.26161% or 0.42826% for interest periods of one, three or six months, respectively. Applicable SOFR Margin is the sum of (a) the product of (i) the Subscription Secured Borrowings percentage calculated for such period and (ii) 1.75% and (b) the product of (i) the Portfolio Secured Borrowings percentage for such period and (ii) 2.50%. When the Fund is using 50.00% or more of the maximum amount available under the Loan Agreement, the applicable unused line fee is 0.25% of the unused portion of the loan facility; otherwise, the applicable unused line fee is 0.50% of the unused portion. The Fund pays the unused credit line fee quarterly. As of June 30, 2026, $128.0 million was outstanding under the facility.

Amounts disbursed under the Fund’s loan commitments were $65.3 million for the six months ended June 30, 2026. Net loan amounts outstanding after amortization and valuation adjustments decreased by $73.7 million for the same period. Unexpired unfunded commitments totaled $85.8 million as of June 30, 2026.

As of Cumulative Amount Disbursed Principal Reductions and Fair Market AdjustmentsBalance Outstanding - Fair Value Unexpired Unfunded Commitments
June 30, 2026$942.1 million$617.7 million$324.4 million$85.8 million
December 31, 2025$876.8 million$478.7 million$398.1 million$82.5 million

The unexpired unfunded commitments by portfolio company as of June 30, 2026 and December 31, 2025 are detailed in Note 9 to the financial statements included in this filing.


33


Because venture loans are privately negotiated transactions, investments in these assets are relatively illiquid. It is Management’s experience that not all unexpired unfunded commitments will be used by borrowers. Many credit agreements contain provisions that are milestone dependent and not all borrowers will achieve these milestones. Additionally, the Fund’s credit agreements contain provisions that give relief from funding obligations in the event the borrower has a materially adverse change in its financial condition. Therefore, the unexpired unfunded commitments do not necessarily reflect future cash requirements or future investments for the Fund.

The Fund seeks to maintain the requirements to qualify for the special pass-through status available to RICs under the Code, and thus to be relieved of federal income tax on that part of its net investment income and realized capital gains that it distributes to its shareholder. To qualify as a RIC, the Fund must distribute to its shareholder for each taxable year at least 90% of its investment company taxable income (consisting generally of net investment income and net short-term capital gain) (the “Distribution Requirement”). To the extent that the terms of the Fund’s venture loans provide for the receipt by the Fund of additional interest at the end of the loan term or provide for the receipt by the Fund of a purchase price for the asset at the end of the loan term (“residual income”), the Fund would be required to accrue such residual income over the life of the loan, and to include such accrued undistributed income in its gross income for each taxable year even if it receives no portion of such residual income in that year. Thus, in order to meet the Distribution Requirement and avoid payment of income taxes or an excise tax on undistributed income, the Fund may be required in a particular year to distribute as a dividend an amount in excess of the total amount of income it actually receives. Those distributions will be made from the Fund’s cash assets, from amounts received through amortization of loans or from borrowed funds.

As of June 30, 2026, the Fund had a cash balance of $16.2 million and $137.5 million in scheduled loan receivable payments over the next twelve months. Additionally, the Fund has access to uncalled capital of $73.0 million and recallable capital of $150.8 million as a liquidity source and a borrowing base that grows as it funds additional commitments. These amounts are sufficient to meet the current commitment backlog and operational expenses of the Fund over the next year.

On April 30, 2021, the Fund’s sole shareholder, the Company, approved a reduced asset coverage ratio of 150% for the Fund as permitted in Section 61(a)(2) of the 1940 Act. Accordingly, the Fund is permitted to borrow in any amount so long as its asset coverage ratio, as defined in the 1940 Act, is at least 150% after giving effect to such borrowings. As of June 30, 2026, the Fund’s asset coverage ratio was 267%.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Fund’s business activities contain various elements of risk, of which Management considers interest rate and credit risk to be the principal types of risks. Because the Fund considers the management of risk essential to conducting its business and to maintaining profitability, the Fund’s risk management procedures are designed to identify and analyze the Fund’s risks, to set appropriate policies and limits and to continually monitor these risks and limits by means of reliable administrative and information systems and other policies and programs.

The Fund manages its market risk by maintaining a portfolio that is diverse by industry, size of investment, stage of development, and borrower. The Fund has limited exposure to public market price fluctuations as the Fund primarily invests in private business enterprises and distributes all equity investments upon receipt to the Company.

The Fund’s investments are subject to market risk based on several factors, including, but not limited to, the borrower’s credit history, available cash, support of the borrower’s underlying investors, available liquidity, “burn rate,” revenue income, security interest, secondary markets for collateral, the size of the loan, term of the loan and the ability to exit via initial public offering or merger and acquisition.

The Fund’s exposure to interest rate sensitivity is regularly monitored and analyzed by measuring the characteristics of assets and liabilities. The Fund utilizes various methods to assess interest rate risk in terms of the potential effect on interest income net of interest expense, the value of net assets and the value at risk in an effort to ensure that the Fund is insulated from any significant adverse effects from changes in interest rates. As of June 30, 2026, the outstanding debt balance was $128.0 million with a floating interest rate based on a daily 1-month Adjusted Term SOFR rate of 3.65197%, for which the Fund had derivative instruments in place in the form of interest rate collars with a weighted average ceiling and floor of 4.65% and 3.07%, respectively, on $100.0 million, leaving the Fund with exposure to interest rate changes on the un-hedged portion of the loan.

Because all of the Fund’s loans impose a fixed interest rate upon funding, changes in short-term interest rates will not directly affect interest income associated with the loan portfolio as of June 30, 2026. However, those changes could have the potential to change the Fund’s ability to acquire and renew bank facilities, and engage in other investment activities. Further, changes in short-term interest rates could also affect interest expense and interest on the Fund’s short-term investments.


34


Based on the Fund’s Condensed Statements of Assets and Liabilities as of June 30, 2026, the following table shows the approximate annualized increase (decrease) in components of net assets resulting from operations of hypothetical base rate changes in interest rates, assuming no changes in investments, borrowings, cash balances and derivative instruments.

Effect of Interest Rate Change ByIncrease (Decrease) in Other Income Gain (Loss) from Interest Rate Collar(Increase) Decrease in Interest ExpenseIncrease (Decrease) in Total Income
(2.00)%$(323,517)$(1,418,030)$2,560,000 $818,453 
(1.00)%$(161,758)$(418,030)$1,280,000 $700,212 
(0.50)%$(80,879)$(44,015)$640,000 $515,106 
0.50%$80,879 $75,985 $(640,000)$(483,136)
1.00%$161,758 $325,985 $(1,280,000)$(792,257)
2.00%$323,517 $1,001,970 $(2,560,000)$(1,234,513)

Additionally, a change in the interest rate may affect the fair value of the derivative instruments and affect net change in unrealized gain or loss from derivative instruments. The amount of any such effect will be contingent upon market expectations for future interest rate changes. Any increases in expected future rates will increase the fair value of the derivative instruments while any rate decreases will decrease the fair value.

Although Management believes that the foregoing analysis is indicative of the Fund’s sensitivity to interest rate changes, it does not take into consideration potential changes in the credit market, credit quality, size and composition of the assets in the portfolio. It also does not assume any new fundings to borrowers, repayments from borrowers or defaults on borrowings. Accordingly, no assurances can be given that actual results would not differ materially from the table above.

Because the Fund currently borrows, its net investment income is highly dependent upon the difference between the rate at which it borrows and the rate at which it invests the amounts borrowed. Accordingly, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on the Fund’s investment activities and net investment income. The Fund’s exposure to movement in short-term interest rates stems from the Fund borrowing at a floating interest rate but then making loans with a fixed rate at the time the loans are extended.

The Fund is not sensitive to changes in foreign currency exchange rates, commodity prices and other market rates or prices.


Item 4.  Controls and Procedures

Disclosure Controls and Procedures:

At the end of the period covered by this report, the Fund carried out an evaluation under the supervision and with the participation of its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Fund’s disclosure controls and procedures pursuant to Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934 (“Exchange Act”). Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Fund’s disclosure controls and procedures were effective as of the end of the period in ensuring that information required to be disclosed was recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and in providing reasonable assurance that information required to be disclosed by the Fund in such reports is accumulated and communicated to the Fund’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Controls:

There have not been any changes in the Fund’s internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the Fund’s fiscal quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Fund’s internal control over financial reporting.
35


PART II — OTHER INFORMATION

Item 1. Legal Proceedings

The Fund may become party to certain lawsuits from time to time in the normal course of business. While the outcome of any legal proceedings cannot now be predicted with certainty, the Fund does not expect any such proceedings will have a material effect upon the Fund’s financial condition or results of operations. Management is not aware of any pending legal proceedings involving the Fund. The Fund is not a party to any material legal proceedings.

Item 1A. Risk Factors

None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.  Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Rule 10b5-1 Trading Arrangements

During the fiscal quarter ended June 30, 2026, no director or officer of the Fund adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation S-K).

36


Item 6. Exhibits
Exhibit NumberDescription
3.1
3.2
4.1
10.1
10.2
10.3
31.1
31.2
32.1
32.2

37


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

WTI Fund X, INC.
(Registrant)

By:/s/ David R. WanekBy:/s/ Jared S. Thear
David R. WanekJared S. Thear
President and Chief Executive OfficerChief Financial Officer
(Principal Executive Officer)(Principal Financial Officer)
Date:August 13, 2026Date:August 13, 2026


38